https://biolegacyresearch.com/cder-shifts-dispute-resolution-program-due-to-spike-in-generic-appeals/ 2018-06-11T22:03:36+00:00 https://biolegacyresearch.com/azar-testifies-on-drug-pricing-criticizes-pbms-and-rebates/ 2018-06-12T21:58:04+00:00 https://biolegacyresearch.com/fda-issues-guidance-on-payor-communications-non-label-information/ 2018-06-12T21:58:52+00:00 https://biolegacyresearch.com/fda-issues-first-of-four-draft-guidances-on-patient-focused-drug-development/ 2018-06-12T21:59:37+00:00 https://biolegacyresearch.com/massachusetts-becomes-first-state-to-target-opioid-company-executives-in-lawsuit/ 2018-06-12T22:00:22+00:00 https://biolegacyresearch.com/taiwan-biotech-called-out-for-environmental-monitoring/ 2018-06-13T21:26:47+00:00 https://biolegacyresearch.com/fda-suggests-alternatives-for-demonstrating-cgmp-compliance-for-combination-products/ 2018-06-13T21:45:11+00:00 https://biolegacyresearch.com/fda-issues-draft-guidance-on-developing-hiv-prevention-drugs/ 2018-06-13T21:46:17+00:00 https://biolegacyresearch.com/court-rules-fda-must-grant-orphan-drug-exclusivity-for-bendeka/ 2018-06-13T21:47:33+00:00 https://biolegacyresearch.com/ema-conducts-fewer-gmp-more-gcp-and-pharmacovigilance-inspections/ 2018-06-14T21:21:29+00:00 https://biolegacyresearch.com/mhra-cites-data-management-and-integrity-in-gcp-inspections/ 2018-06-14T21:22:55+00:00 https://biolegacyresearch.com/time-between-fda-inspections-and-classification-letters-shrinking/ 2018-06-14T21:23:56+00:00 https://biolegacyresearch.com/tga-overhauls-advisory-committee-conflicts-of-interest-guidance/ 2018-06-14T21:25:40+00:00 https://biolegacyresearch.com/fda-clarifies-outsourcing-facility-requirements-for-503a-compounders/ 2018-06-14T21:26:03+00:00 https://biolegacyresearch.com/cder-shifts-dispute-resolution-program-due-to-spike-in-appeals/ 2018-06-14T21:29:51+00:00 https://biolegacyresearch.com/house-passes-25-opioid-crisis-related-bills/ 2018-06-14T21:47:20+00:00 https://biolegacyresearch.com/house-bill-would-strengthen-340b-programs-opioid-crisis-resources/ 2018-06-14T21:48:14+00:00 https://biolegacyresearch.com/endo-announces-settlement-of-all-remaining-testosterone-replacement-liability-suits/ 2018-06-14T21:49:13+00:00 https://biolegacyresearch.com/ema-proposes-single-guide-for-clinical-evaluations-of-bacterial-infection-treatments/ 2018-06-14T21:51:16+00:00 https://biolegacyresearch.com/hatch-amendment-would-offer-generic-litigants-patent-appeal-choice/ 2018-06-15T22:06:43+00:00 https://biolegacyresearch.com/house-passes-bill-cracking-down-on-synthetic-opioids/ 2018-06-15T22:07:28+00:00 https://biolegacyresearch.com/survey-shows-u-s-trust-in-pharma-plummets-amid-rising-prices-opioid-crisis/ 2018-06-15T22:08:12+00:00 https://biolegacyresearch.com/montreal-manufacturer-called-out-for-cleaning-testing-issues/ 2018-06-15T22:08:58+00:00 https://biolegacyresearch.com/common-rule-delayed-another-six-months-in-hhs-final-rule/ 2018-06-18T22:05:58+00:00 https://biolegacyresearch.com/gottlieb-flags-two-fda-initiatives-to-speed-generic-reviews/ 2018-06-18T22:06:53+00:00 https://biolegacyresearch.com/fda-overhauls-manual-on-inter-center-consultations-for-combination-products/ 2018-06-18T22:07:39+00:00 https://biolegacyresearch.com/indian-api-manufacturer-called-out-for-numerous-violations/ 2018-06-18T22:08:27+00:00 https://biolegacyresearch.com/judge-grants-restraining-order-against-dr-reddys-suboxone-generic/ 2018-06-19T21:06:00+00:00 https://biolegacyresearch.com/fda-warns-otc-manufacturer-for-differences-between-electronic-records-labeling/ 2018-06-19T21:07:00+00:00 https://biolegacyresearch.com/hhs-seeks-more-authority-for-340b-pricing-data-collection-and-oversight/ 2018-06-19T21:55:38+00:00 https://biolegacyresearch.com/fda-reports-challenging-year-for-drug-shortages-senate-requests-task-force/ 2018-06-19T21:56:28+00:00 https://biolegacyresearch.com/fda-issues-draft-guidance-on-drug-development-for-major-depressive-disorder/ 2018-06-20T21:49:37+00:00 https://biolegacyresearch.com/fda-spells-out-options-for-pdufa-waivers/ 2018-06-20T21:50:22+00:00 https://biolegacyresearch.com/ema-unveils-online-portal-for-orphan-drug-designations/ 2018-06-20T21:51:06+00:00 https://biolegacyresearch.com/fda-hits-texas-compounder-for-inadequate-documentation-gmp-issues/ 2018-06-20T21:51:53+00:00 https://biolegacyresearch.com/white-house-proposes-name-change-for-fda-shift-of-food-oversight-to-usda/ 2018-06-21T21:30:23+00:00 https://biolegacyresearch.com/fda-pulls-biosimilar-analytics-guidance-amid-comments-on-flexibility/ 2018-06-21T21:31:07+00:00 https://biolegacyresearch.com/ny-judge-rejects-opioid-makers-request-for-dismissal-of-eight-lawsuits/ 2018-06-21T21:31:56+00:00 https://biolegacyresearch.com/consumer-group-calls-for-withdrawal-of-takedas-gout-treatment/ 2018-06-21T21:32:47+00:00 https://biolegacyresearch.com/house-passes-spate-of-opioid-crisis-legislation-for-second-straight-week/ 2018-06-22T21:38:38+00:00 https://biolegacyresearch.com/ema-fda-discuss-mutual-recognition-generics-at-annual-meeting/ 2018-06-22T21:39:38+00:00 https://biolegacyresearch.com/fda-approves-ferrings-nocdurna-nda-nixing-two-petitions/ 2018-06-22T21:41:56+00:00 https://biolegacyresearch.com/cber-launches-program-to-meet-with-sponsors-to-advance-early-product-development/ 2018-06-22T21:42:52+00:00 https://biolegacyresearch.com/gottlieb-says-cancer-drug-surrogate-endpoints-will-be-released-for-first-time/ 2018-06-25T20:36:35+00:00 https://biolegacyresearch.com/ohio-calls-for-new-pbm-pricing-model-amid-report-finding-two-pbms-took-in-223-million/ 2018-06-25T20:37:38+00:00 https://biolegacyresearch.com/senators-ask-ftc-to-analyze-how-pay-for-delay-deals-affect-biosimilar-access/ 2018-06-25T20:38:28+00:00 https://biolegacyresearch.com/french-drugmaker-gets-warning-letter-for-testing-deficiencies-process-validation-issues/ 2018-06-25T20:39:16+00:00 https://biolegacyresearch.com/joint-fda-advisory-committee-votes-not-to-recommend-pain-therapeutics-oxycodone-nda/ 2018-06-26T21:47:16+00:00 https://biolegacyresearch.com/michigan-democrats-seek-to-overturn-states-anti-liability-suit-law/ 2018-06-26T21:48:12+00:00 https://biolegacyresearch.com/chinese-manufacturer-draws-fda-warning-for-adulterated-apis/ 2018-06-26T21:49:11+00:00 https://biolegacyresearch.com/novartis-bio-suggest-expanding-hematologic-disorder-guidance/ 2018-06-26T21:51:23+00:00 https://biolegacyresearch.com/tga-adjusts-mandatory-shortage-reporting-window-based-on-stakeholder-feedback/ 2018-06-26T21:52:35+00:00 https://biolegacyresearch.com/reduced-opioid-prescribing-has-increased-online-drug-trafficking-warns-gottlieb/ 2018-06-27T21:22:15+00:00 https://biolegacyresearch.com/new-york-republicans-send-drug-take-back-bill-to-governors-desk/ 2018-06-27T21:22:58+00:00 https://biolegacyresearch.com/senate-minority-report-says-tangled-web-to-blame-for-higher-drug-costs/ 2018-06-27T21:23:43+00:00 https://biolegacyresearch.com/surmasis-reprimanded-for-laboratory-records-equipment-inspections/ 2018-06-27T21:24:32+00:00 https://biolegacyresearch.com/fda-issues-final-guidance-on-bsufa-ii-fees/ 2018-06-28T21:29:23+00:00 https://biolegacyresearch.com/fda-oncology-radiopharmaceutical-labeling-must-include-genotoxicity/ 2018-06-28T21:30:08+00:00 https://biolegacyresearch.com/new-cder-initiatives-will-gather-feedback-on-quality-metrics/ 2018-06-28T21:30:59+00:00 https://biolegacyresearch.com/fda-seeks-industry-volunteers-for-2018-quality-metrics-site-visit-program/ 2018-06-28T21:32:02+00:00 https://biolegacyresearch.com/gottlieb-vows-further-enforcement-action-against-compounders-outsourcing-facilities/ 2018-06-29T21:34:21+00:00 https://biolegacyresearch.com/supreme-court-will-hear-merck-failure-to-warn-case/ 2018-06-29T21:35:04+00:00 https://biolegacyresearch.com/chmp-recommends-nine-drugs-for-approval-including-six-orphans/ 2018-06-29T21:35:45+00:00 https://biolegacyresearch.com/mylan-draws-483-for-cleaning-and-maintenance-quality-control-issues/ 2018-06-29T21:36:32+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-warns-five-firms-for-quality-deficiencies/ 2018-07-02T18:05:33+00:00 https://biolegacyresearch.com/surmasis-reprimanded-for-lab-records-equipment-inspections/ 2018-07-02T18:06:32+00:00 https://biolegacyresearch.com/montreal-manufacturer-cited-for-cleaning-testing-issues/ 2018-07-02T18:08:37+00:00 https://biolegacyresearch.com/ftc-hails-record-setting-448-million-victory-over-testosterone-replacement-gel/ 2018-07-02T21:50:32+00:00 https://biolegacyresearch.com/fda-sends-pfizer-untitled-letter-for-leaving-risks-out-of-promotional-video/ 2018-07-02T21:51:00+00:00 https://biolegacyresearch.com/drug-distributor-sues-novartis-par-for-scheme-to-delay-generic-exforge/ 2018-07-02T21:51:16+00:00 https://biolegacyresearch.com/phrma-bio-and-nevada-agree-to-end-price-transparency-litigation/ 2018-07-02T21:52:48+00:00 https://biolegacyresearch.com/u-s-attorney-sues-herbal-drugmaker-over-unapproved-drugs/ 2018-07-04T20:40:00+00:00 https://biolegacyresearch.com/fda-issues-final-guidance-for-anda-pas-amendments-under-gdufa-ii/ 2018-07-04T20:40:00+00:00 https://biolegacyresearch.com/chinese-api-manufacturer-draws-fda-warning/ 2018-07-04T20:40:00+00:00 https://biolegacyresearch.com/drug-company-pays-physicians-who-subscribe-high-priced-steroid-gel-study-finds/ 2018-07-04T20:40:00+00:00 https://biolegacyresearch.com/drug-company-pays-physicians-who-subscribe-high-priced-gel-study-finds/ 2018-07-04T20:40:00+00:00 https://biolegacyresearch.com/senate-democrats-target-pharmacy-benefit-managers-distributors/ 2018-07-05T21:03:07+00:00 https://biolegacyresearch.com/amgen-files-patent-infringement-lawsuit-over-accords-sensipar-generic/ 2018-07-05T21:03:57+00:00 https://biolegacyresearch.com/teamsters-call-for-rejection-of-mckessons-audit-committee-chair-criticizing-anti-diversion-practices/ 2018-07-05T21:04:56+00:00 https://biolegacyresearch.com/france-to-beef-up-clinical-trial-requirements-for-flow-diverter-stents/ 2018-07-06T15:30:00+00:00 https://biolegacyresearch.com/time-is-running-out-to-prepare-for-new-eu-mdr-ivdr-medtech-europe/ 2018-07-06T15:30:00+00:00 https://biolegacyresearch.com/fda-issues-draft-guidance-on-coding-for-ivds/ 2018-07-06T15:30:00+00:00 https://biolegacyresearch.com/fda-offers-labeling-advice-for-devices-with-lubricious-coatings/ 2018-07-06T15:30:00+00:00 https://biolegacyresearch.com/483-roundup-fda-flags-device-firms-for-capas-mdrs-and-complaints/ 2018-07-06T15:30:00+00:00 https://biolegacyresearch.com/fda-updates-software-precertification-program/ 2018-07-06T15:30:00+00:00 https://biolegacyresearch.com/fda-suggests-alternatives-for-complying-with-qs-requirements/ 2018-07-06T15:30:00+00:00 https://biolegacyresearch.com/fda-issues-draft-labeling-guidance-on-indications-and-usage/ 2018-07-06T21:20:22+00:00 https://biolegacyresearch.com/judge-throws-out-140-million-verdict-in-abbvie-androgel-case-orders-new-trial/ 2018-07-06T21:22:12+00:00 https://biolegacyresearch.com/genentech-sues-lilly-within-hours-of-patent-being-issued/ 2018-07-06T21:23:32+00:00 https://biolegacyresearch.com/california-otc-drugmaker-flagged-for-numerous-violations/ 2018-07-06T21:24:51+00:00 https://biolegacyresearch.com/trump-blasts-pfizer-for-raising-drug-prices/ 2018-07-09T20:55:00+00:00 https://biolegacyresearch.com/fda-to-team-up-with-medical-community-on-opioid-guidelines-gottlieb-says/ 2018-07-09T20:56:14+00:00 https://biolegacyresearch.com/tennessee-lawsuit-purdue-ignored-provider-misconduct-red-flags/ 2018-07-09T20:57:24+00:00 https://biolegacyresearch.com/fda-nixes-united-therapeutics-petition-on-tyvaso-referencing-combination-products/ 2018-07-09T20:58:22+00:00 https://biolegacyresearch.com/chinese-api-manufacturer-cited-for-quality-shortcomings/ 2018-07-10T21:49:21+00:00 https://biolegacyresearch.com/several-animal-studies-needed-for-smallpox-drug-testing-fda-says/ 2018-07-10T21:56:09+00:00 https://biolegacyresearch.com/fda-updates-warnings-for-fluoroquinolone-antibiotics/ 2018-07-10T21:57:20+00:00 https://biolegacyresearch.com/ema-many-uk-drugmakers-are-behind-schedule-on-brexit-preparedness/ 2018-07-10T21:58:17+00:00 https://biolegacyresearch.com/aam-calls-for-time-estimates-clarifications-in-supply-chain-waiver-guidance/ 2018-07-10T21:59:11+00:00 https://biolegacyresearch.com/tga-adjusts-shortage-reporting-window-based-on-feedback/ 2018-07-11T20:38:45+00:00 https://biolegacyresearch.com/fda-reports-challenging-year-for-drug-shortages/ 2018-07-11T20:41:58+00:00 https://biolegacyresearch.com/ema-proposes-single-clinical-guide-for-bacterial-infection-treatments/ 2018-07-11T20:43:44+00:00 https://biolegacyresearch.com/ema-fda-officials-discuss-mutual-recognition-generics/ 2018-07-11T20:45:21+00:00 https://biolegacyresearch.com/fda-issues-advice-on-limited-population-pathway-for-antimicrobials/ 2018-07-11T20:48:53+00:00 https://biolegacyresearch.com/fda-issues-two-guidances-on-payor-communications-non-label-information/ 2018-07-11T20:49:55+00:00 https://biolegacyresearch.com/fda-issues-final-guidance-for-anda-amendments-under-gdufa-ii/ 2018-07-11T20:51:04+00:00 https://biolegacyresearch.com/survey-shows-u-s-trust-in-pharma-plummets-amid-rising-prices/ 2018-07-11T20:52:24+00:00 https://biolegacyresearch.com/fda-releases-new-draft-guidances-on-gene-therapies/ 2018-07-11T21:56:40+00:00 https://biolegacyresearch.com/doj-finalizes-expanded-dea-anti-diversion-powers/ 2018-07-11T21:57:27+00:00 https://biolegacyresearch.com/fda-hits-arog-pharmaceuticals-with-untitled-letter-over-promotional-tactics/ 2018-07-11T21:58:00+00:00 https://biolegacyresearch.com/cosmo-files-second-patent-suit-against-actavis-over-generic-uceris/ 2018-07-11T21:59:01+00:00 https://biolegacyresearch.com/raniers-compounding-laboratory-draws-form-483-safety-alert-over-sterility-issues/ 2018-07-11T21:59:45+00:00 https://biolegacyresearch.com/fda-to-create-new-drug-shortage-task-force/ 2018-07-12T22:28:08+00:00 https://biolegacyresearch.com/expert-group-approves-safety-efficacy-of-gsks-malaria-drug/ 2018-07-12T22:28:55+00:00 https://biolegacyresearch.com/drug-distributors-challenge-new-york-law-over-opioid-fines/ 2018-07-12T22:29:42+00:00 https://biolegacyresearch.com/fda-issues-alert-about-fake-warning-letters-to-internet-and-phone-drug-buyers/ 2018-07-13T21:17:54+00:00 https://biolegacyresearch.com/fda-draft-guidance-outlines-approval-pathways-for-antihypertension-drug-studies/ 2018-07-13T21:18:00+00:00 https://biolegacyresearch.com/senate-dems-novartis-misleadingly-downplayed-relationship-with-trump-lawyer/ 2018-07-13T21:19:50+00:00 https://biolegacyresearch.com/senate-report-calls-for-stronger-dea-control-over-opioid-distribution/ 2018-07-13T21:21:08+00:00 https://biolegacyresearch.com/indivior-wins-injunction-against-dr-reddys-suboxone-generic/ 2018-07-16T21:46:35+00:00 https://biolegacyresearch.com/pfizers-hospira-facility-in-india-hit-with-lengthy-483/ 2018-07-16T21:47:52+00:00 https://biolegacyresearch.com/ema-publishes-first-update-on-its-clinical-data-open-access-policy/ 2018-07-16T21:48:42+00:00 https://biolegacyresearch.com/fda-takes-kansas-city-manufacturer-to-task-over-serious-sanitation-violations/ 2018-07-16T21:49:26+00:00 https://biolegacyresearch.com/fda-may-extend-nda-pathway-to-increase-access-to-nonprescription-drugs/ 2018-07-17T21:04:31+00:00 https://biolegacyresearch.com/house-passes-legislation-for-otc-monograph-program-reform/ 2018-07-17T21:05:34+00:00 https://biolegacyresearch.com/drugmakers-take-aim-at-pharmacy-benefits-manager/ 2018-07-17T21:06:22+00:00 https://biolegacyresearch.com/baxter-facility-warned-for-serious-production-failures-poor-conditions/ 2018-07-17T21:07:16+00:00 https://biolegacyresearch.com/fda-unveils-action-plan-to-boost-biosimilars/ 2018-07-18T22:42:12+00:00 https://biolegacyresearch.com/fda-says-biosimilar-sponsors-should-include-reference-product-on-labeling/ 2018-07-18T22:43:19+00:00 https://biolegacyresearch.com/fda-urges-drug-sponsors-to-ensure-data-is-interoperable-or-integrated/ 2018-07-18T22:45:07+00:00 https://biolegacyresearch.com/fda-issues-draft-recommendations-on-submitting-field-alert-reports/ 2018-07-18T22:46:10+00:00 https://biolegacyresearch.com/woodcock-outlines-reorganization-of-cder-offices/ 2018-07-19T21:06:03+00:00 https://biolegacyresearch.com/fda-to-weigh-options-for-importing-single-source-drugs/ 2018-07-19T21:08:02+00:00 https://biolegacyresearch.com/fda-warns-california-drugmaker-for-testing-deficiencies-missing-quality-unit/ 2018-07-19T21:09:40+00:00 https://biolegacyresearch.com/fda-cites-minneapolis-compounding-pharmacy-over-sanitation-issues/ 2018-07-20T21:01:08+00:00 https://biolegacyresearch.com/fda-issues-new-draft-guidances-for-generic-trials/ 2018-07-20T21:20:05+00:00 https://biolegacyresearch.com/fda-adopts-ich-e17-guidance-on-multiregional-clinical-trials/ 2018-07-20T21:21:51+00:00 https://biolegacyresearch.com/pbms-voice-concern-over-proposal-to-remove-protections-for-drug-rebates/ 2018-07-20T21:23:18+00:00 https://biolegacyresearch.com/connecticut-drugmaker-flagged-for-repeat-violations/ 2018-07-23T21:10:41+00:00 https://biolegacyresearch.com/fda-moves-against-cesium-chloride-as-bulk-substance-in-compounded-drugs/ 2018-07-23T22:02:23+00:00 https://biolegacyresearch.com/trials-for-inherited-metabolic-disorders-should-put-patients-on-strict-diets-fda-says/ 2018-07-23T22:03:08+00:00 https://biolegacyresearch.com/court-finds-st-regis-tribe-cannot-block-allergan-patent-challenges/ 2018-07-23T22:03:55+00:00 https://biolegacyresearch.com/fda-draft-guidance-outlines-use-of-liquids-or-soft-foods-as-drug-vehicles/ 2018-07-24T21:43:42+00:00 https://biolegacyresearch.com/novartis-sues-over-generics-for-gilenya-after-favorable-pto-ruling/ 2018-07-24T21:44:00+00:00 https://biolegacyresearch.com/ema-adopts-revised-drug-development-guidelines-for-two-inflammatory-diseases/ 2018-07-24T21:45:25+00:00 https://biolegacyresearch.com/edge-biologicals-called-out-for-inadequate-procedures-recordkeeping/ 2018-07-24T21:46:27+00:00 https://biolegacyresearch.com/senate-help-committee-advances-bill-to-ban-pharmacy-gag-clauses/ 2018-07-25T21:39:53+00:00 https://biolegacyresearch.com/fda-advisory-committee-splits-on-copd-indication-for-glaxosmithkline-drug/ 2018-07-25T21:41:43+00:00 https://biolegacyresearch.com/opioid-manufacturers-sue-black-market-drug-distributors/ 2018-07-25T22:18:37+00:00 https://biolegacyresearch.com/fda-lists-surrogate-endpoints-for-drug-sponsors/ 2018-07-25T22:25:14+00:00 https://biolegacyresearch.com/fda-issues-final-guidance-closing-pediatric-orphan-drug-loophole/ 2018-07-26T21:42:09+00:00 https://biolegacyresearch.com/advisory-group-recommends-safety-efficacy-of-malaria-nda/ 2018-07-26T21:43:04+00:00 https://biolegacyresearch.com/fda-hikes-generic-drug-application-fees-for-fy-2019/ 2018-07-26T21:45:00+00:00 https://biolegacyresearch.com/fda-issues-advice-on-replacement-or-corrective-therapies-for-certain-rare-diseases/ 2018-07-26T22:01:41+00:00 https://biolegacyresearch.com/woodcock-introduces-new-quality-metrics-programs/ 2018-07-27T21:28:31+00:00 https://biolegacyresearch.com/astrazeneca-sues-accord-to-protect-faslodex-patents/ 2018-07-27T21:29:25+00:00 https://biolegacyresearch.com/cder-updates-staff-guidance-on-pharmacologic-classes-for-prescribing-information/ 2018-07-27T21:30:26+00:00 https://biolegacyresearch.com/fda-warns-compounder-its-not-exempt-from-oversight/ 2018-07-27T21:31:18+00:00 https://biolegacyresearch.com/house-ec-committee-calls-on-ftc-to-review-pbm-mergers/ 2018-07-30T21:54:37+00:00 https://biolegacyresearch.com/fda-lowers-some-bsufa-ii-fees-for-fiscal-2019/ 2018-07-30T21:55:21+00:00 https://biolegacyresearch.com/ema-updates-guidelines-on-submitting-requests-for-orphan-status/ 2018-07-30T21:56:49+00:00 https://biolegacyresearch.com/australian-api-manufacturer-hit-for-quality-failures-non-conformance/ 2018-07-30T21:57:48+00:00 https://biolegacyresearch.com/pfizer-ceo-predicts-trump-administration-will-eliminate-drug-rebates/ 2018-07-31T21:46:20+00:00 https://biolegacyresearch.com/fda-announces-fy-2019-fees-for-outsourcing-facilities/ 2018-07-31T21:47:46+00:00 https://biolegacyresearch.com/who-posts-qa-to-clarify-guidelines-on-biosimilars/ 2018-07-31T21:48:34+00:00 https://biolegacyresearch.com/japanese-api-maker-draws-fda-warning-for-data-integrity-failures/ 2018-07-31T21:49:18+00:00 https://biolegacyresearch.com/mckaskill-to-medicare-negotiate-better-save-billions/ 2018-08-01T21:54:48+00:00 https://biolegacyresearch.com/fda-seeks-expert-feedback-on-rems-for-fentanyl-products/ 2018-08-01T21:55:35+00:00 https://biolegacyresearch.com/federal-court-okays-remicade-biosimilar/ 2018-08-01T21:56:19+00:00 https://biolegacyresearch.com/fda-cites-akorn-for-contamination-protections-aseptic-processing/ 2018-08-01T21:57:02+00:00 https://biolegacyresearch.com/ema-to-further-scale-back-activities-as-brexit-creates-staff-upheaval/ 2018-08-02T22:25:54+00:00 https://biolegacyresearch.com/n-j-supreme-court-throws-out-plaintiffs-expert-testimony-in-accutane-mdl/ 2018-08-02T22:26:54+00:00 https://biolegacyresearch.com/civil-liberties-group-urges-fda-to-stop-issuing-improper-guidance/ 2018-08-02T22:27:53+00:00 https://biolegacyresearch.com/stakeholders-respond-to-congress-on-medical-device-cybersecurity/ 2018-08-03T15:32:43+00:00 https://biolegacyresearch.com/brazil-introduces-firsts-unique-device-identifier-requirements/ 2018-08-03T15:33:56+00:00 https://biolegacyresearch.com/fda-cautions-bayer-over-postmarket-requirements-for-essure/ 2018-08-03T15:34:51+00:00 https://biolegacyresearch.com/imdrf-opens-consultations-on-aers-principles-for-labeling-and-udis/ 2018-08-03T15:35:50+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-six-device-firms-for-gmp-issues/ 2018-08-03T15:37:19+00:00 https://biolegacyresearch.com/fda-updates-guidance-on-510ks-for-expandable-biliary-stents/ 2018-08-03T15:38:32+00:00 https://biolegacyresearch.com/switzerland-overhauls-device-manufacturing-certificate-process/ 2018-08-03T15:39:57+00:00 https://biolegacyresearch.com/ec-committee-puts-pressure-on-three-major-drugmakers-regarding-opioid-crisis/ 2018-08-03T21:57:10+00:00 https://biolegacyresearch.com/allergan-says-pfizer-should-cover-damages-in-opioid-lawsuit/ 2018-08-03T21:58:10+00:00 https://biolegacyresearch.com/cardinal-health-unveils-efforts-to-improve-opioid-anti-diversion-tactics/ 2018-08-03T21:59:34+00:00 https://biolegacyresearch.com/endo-settles-texas-off-label-promotion-case-for-13m/ 2018-08-03T22:00:41+00:00 https://biolegacyresearch.com/fda-moves-against-compounder-use-of-cesium-chloride/ 2018-08-06T18:17:43+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-warns-drugmakers-for-variety-of-issues/ 2018-08-06T18:20:20+00:00 https://biolegacyresearch.com/fda-to-drug-sponsors-ensure-data-is-interoperable-or-integrated/ 2018-08-06T18:24:58+00:00 https://biolegacyresearch.com/483-roundup-four-firms-called-out-over-quality-sanitation-concerns/ 2018-08-06T18:26:20+00:00 https://biolegacyresearch.com/fda-suggests-endpoints-for-medication-assisted-treatments-for-opioids/ 2018-08-06T21:37:00+00:00 https://biolegacyresearch.com/fda-drafts-guidance-for-nicotine-containing-smoking-cessation-drugs/ 2018-08-06T21:38:51+00:00 https://biolegacyresearch.com/mhra-brexit-wont-change-eu-drug-market-access/ 2018-08-06T21:44:52+00:00 https://biolegacyresearch.com/milbar-laboratories-warned-for-contaminated-product/ 2018-08-06T21:45:44+00:00 https://biolegacyresearch.com/humana-sues-dozens-of-generic-drugmakers-over-alleged-price-fixing/ 2018-08-07T21:24:36+00:00 https://biolegacyresearch.com/canadian-manufacturer-warned-for-adulterated-apis/ 2018-08-07T21:25:49+00:00 https://biolegacyresearch.com/fda-issues-guidance-on-controlling-elemental-impurities-in-drugs/ 2018-08-07T21:54:00+00:00 https://biolegacyresearch.com/fda-panel-endorses-insmeds-lung-disease-nda-for-narrow-indication/ 2018-08-07T22:01:46+00:00 https://biolegacyresearch.com/fda-grants-first-approvals-via-the-competitive-generic-therapy-pathway/ 2018-08-08T22:08:07+00:00 https://biolegacyresearch.com/fda-panel-recommends-ndas-for-bacterial-pneumonia-skin-infections/ 2018-08-08T22:08:54+00:00 https://biolegacyresearch.com/cms-to-employ-step-therapy-to-lower-drug-costs/ 2018-08-08T22:09:46+00:00 https://biolegacyresearch.com/fda-finalizes-dissolution-testing-guidance-for-immediate-release-solid-oral-dosage-forms/ 2018-08-08T22:10:43+00:00 https://biolegacyresearch.com/insys-pays-millions-to-settle-bribery-probe/ 2018-08-08T22:11:30+00:00 https://biolegacyresearch.com/astrazeneca-agrees-to-110-million-settlement-in-texas-medical-fraud-cases/ 2018-08-08T22:12:19+00:00 https://biolegacyresearch.com/fda-drafts-guidance-for-inhaled-nicotine-containing-drugs/ 2018-08-09T20:32:49+00:00 https://biolegacyresearch.com/ema-uk-drugmakers-are-behind-schedule-on-brexit-preparedness/ 2018-08-09T20:34:31+00:00 https://biolegacyresearch.com/pbms-concerned-over-proposal-to-remove-drug-rebate-protections/ 2018-08-09T20:39:01+00:00 https://biolegacyresearch.com/aam-calls-for-clarifications-in-supply-chain-waiver-guidance/ 2018-08-09T20:41:02+00:00 https://biolegacyresearch.com/fda-issues-guidance-on-endpoints-for-opioid-mats/ 2018-08-09T20:42:51+00:00 https://biolegacyresearch.com/hhs-finds-questionable-billing-for-compounded-topical-drugs-in-medicare-part-d/ 2018-08-09T21:51:52+00:00 https://biolegacyresearch.com/louisiana-floats-subscription-based-payment-model-for-hep-c-drugs/ 2018-08-09T21:52:42+00:00 https://biolegacyresearch.com/fda-cites-teva-supplier-celltrion-in-follow-up-inspection/ 2018-08-09T21:53:31+00:00 https://biolegacyresearch.com/doj-cracks-down-on-illegal-synthetic-opioids/ 2018-08-10T21:48:36+00:00 https://biolegacyresearch.com/fda-focus-on-hardest-to-treat-in-cohort-cancer-trials/ 2018-08-10T21:49:46+00:00 https://biolegacyresearch.com/doj-joins-suboxone-whistleblower-cases/ 2018-08-10T21:51:11+00:00 https://biolegacyresearch.com/lawmakers-urge-white-house-to-close-gaps-in-tb-prevention-treatment/ 2018-08-10T22:25:57+00:00 https://biolegacyresearch.com/fda-found-repeat-quality-deficiencies-at-valsartan-manufacturers-facility/ 2018-08-10T22:27:18+00:00 https://biolegacyresearch.com/pennsylvania-court-shoots-down-jjs-motion-to-dismiss-pfizers-antitrust-lawsuit/ 2018-08-13T21:43:50+00:00 https://biolegacyresearch.com/hatch-walden-urge-omb-to-analyze-effects-of-drug-rebate-reform-on-industry/ 2018-08-13T21:47:20+00:00 https://biolegacyresearch.com/stakeholders-seek-clarification-of-fdas-adolescent-oncology-patient-guidance/ 2018-08-13T22:00:58+00:00 https://biolegacyresearch.com/fda-calls-out-korean-manufacturer-over-contamination-concerns/ 2018-08-13T22:04:56+00:00 https://biolegacyresearch.com/doj-forms-new-healthcare-fraud-opioid-prescription-strike-force-for-newark-philadelphia/ 2018-08-14T21:25:59+00:00 https://biolegacyresearch.com/tga-calls-for-comments-on-proposed-boxed-warning-requirements/ 2018-08-14T21:26:49+00:00 https://biolegacyresearch.com/indian-drugmaker-draws-fda-warning-for-adulterated-products/ 2018-08-14T21:27:34+00:00 https://biolegacyresearch.com/aids-nonprofit-asks-supreme-court-to-hear-case-against-gilead/ 2018-08-14T21:32:08+00:00 https://biolegacyresearch.com/ohio-medicaid-will-require-pbms-to-use-transparent-pass-through-pricing/ 2018-08-15T21:42:19+00:00 https://biolegacyresearch.com/new-york-sues-purdue-over-fraudulent-claims-for-opioids/ 2018-08-15T21:43:16+00:00 https://biolegacyresearch.com/drugmakers-seek-more-details-on-lpad-pathway-draft-guidance/ 2018-08-15T21:45:14+00:00 https://biolegacyresearch.com/chinese-api-maker-warned-for-repeat-violations/ 2018-08-15T21:46:09+00:00 https://biolegacyresearch.com/westminster-recalls-two-thyroid-drugs-due-to-api-suppliers-deficiencies/ 2018-08-16T21:56:58+00:00 https://biolegacyresearch.com/endo-resumes-lawsuit-against-fda-over-bulk-drug-compounding-decree/ 2018-08-16T21:57:47+00:00 https://biolegacyresearch.com/doj-dea-to-tighten-quotas-for-commonly-abused-opioids/ 2018-08-16T22:15:18+00:00 https://biolegacyresearch.com/phrma-hits-governors-ideas-for-drug-price-cuts/ 2018-08-16T22:16:08+00:00 https://biolegacyresearch.com/pbms-deny-link-between-price-hikes-and-rebates/ 2018-08-17T21:52:41+00:00 https://biolegacyresearch.com/pbms-distributors-deny-azar-allegations-on-drug-price-cuts/ 2018-08-17T21:53:26+00:00 https://biolegacyresearch.com/fda-warns-arizona-manufacturer-about-quality-issues/ 2018-08-17T21:54:29+00:00 https://biolegacyresearch.com/johns-hopkins-panel-recommends-post-op-opioid-guidelines/ 2018-08-17T22:32:07+00:00 https://biolegacyresearch.com/fda-guidance-on-quality-chewables/ 2018-08-20T21:52:39+00:00 https://biolegacyresearch.com/fda-finalizes-guidance-on-microdose-radiopharmaceutical-diagnostic-drugs/ 2018-08-20T21:53:25+00:00 https://biolegacyresearch.com/fda-hits-chinese-api-manufacturer-for-testing-violations/ 2018-08-20T21:54:17+00:00 https://biolegacyresearch.com/drugmakers-to-fda-lift-monotherapy-restriction-in-mdd-guidance/ 2018-08-20T21:58:03+00:00 https://biolegacyresearch.com/hhs-first-100-days-of-drug-pricing-blueprint/ 2018-08-21T21:40:44+00:00 https://biolegacyresearch.com/pharmacy-chains-sue-abbvie-over-alleged-delays-of-androgel-generics/ 2018-08-21T21:41:29+00:00 https://biolegacyresearch.com/oklahoma-medicaid-implements-value-based-drug-purchasing/ 2018-08-21T21:42:17+00:00 https://biolegacyresearch.com/japanese-drugmaker-draws-fda-warning-for-repeat-offenses/ 2018-08-21T21:43:04+00:00 https://biolegacyresearch.com/fda-releases-new-guidance-on-arthritis-treatments/ 2018-08-22T21:42:42+00:00 https://biolegacyresearch.com/fda-teams-up-with-national-academies-to-improve-opioid-prescribing/ 2018-08-22T21:44:35+00:00 https://biolegacyresearch.com/senator-markey-blasts-fdas-rems-for-opioid-products/ 2018-08-22T21:45:58+00:00 https://biolegacyresearch.com/chinese-otc-maker-placed-on-import-alert-for-testing-violations/ 2018-08-22T21:46:42+00:00 https://biolegacyresearch.com/fda-suggests-new-flexibility-for-blinding-cancer-trials/ 2018-08-23T21:36:35+00:00 https://biolegacyresearch.com/appeals-court-overturns-ruling-finding-gsk-liable-for-generic-users-suicide/ 2018-08-23T21:37:54+00:00 https://biolegacyresearch.com/doj-hits-illegal-opioid-prescribers-with-restraining-orders/ 2018-08-23T21:38:51+00:00 https://biolegacyresearch.com/experts-ask-fda-to-rethink-clinical-trial-exclusion-criteria/ 2018-08-23T21:39:41+00:00 https://biolegacyresearch.com/insurers-advocacy-groups-urge-fda-to-finalize-biosimilar-guidance/ 2018-08-24T21:48:38+00:00 https://biolegacyresearch.com/novartis-prevails-in-antitrust-suits-over-leukemia-drug/ 2018-08-24T21:49:40+00:00 https://biolegacyresearch.com/mexican-manufacturer-cited-for-poor-recordkeeping-investigations/ 2018-08-24T21:50:41+00:00 https://biolegacyresearch.com/senate-passes-amendment-requiring-drug-prices-in-advertisements/ 2018-08-24T21:54:07+00:00 https://biolegacyresearch.com/fda-plans-to-exclude-three-substances-from-503b-list/ 2018-08-27T21:43:27+00:00 https://biolegacyresearch.com/drugmakers-call-for-more-details-in-fda-guidance-on-assessing-pressor-effects/ 2018-08-27T21:44:12+00:00 https://biolegacyresearch.com/generic-drugmakers-denied-rehearing-on-validity-of-vimpat-patent/ 2018-08-27T21:44:53+00:00 https://biolegacyresearch.com/fda-raps-adma-biologics-for-poor-documentation-data-controls/ 2018-08-27T21:45:38+00:00 https://biolegacyresearch.com/illinois-will-provide-more-coverage-for-opioid-addiction-in-2020/ 2018-08-28T21:57:50+00:00 https://biolegacyresearch.com/court-hospira-wasnt-protected-by-safe-harbor-in-70-million-biosimilars-case/ 2018-08-28T21:58:51+00:00 https://biolegacyresearch.com/valsartan-lawsuit-targets-one-distributor-two-pharmacies/ 2018-08-28T21:59:58+00:00 https://biolegacyresearch.com/seattle-compounder-warned-over-sterility-issues/ 2018-08-28T22:00:45+00:00 https://biolegacyresearch.com/pfizer-calls-for-guidance-on-misleading-biosimilar-related-communications/ 2018-08-28T22:02:40+00:00 https://biolegacyresearch.com/fda-invites-meeting-requests-for-pilot-program-to-spur-clinical-trial-innovation/ 2018-08-29T21:48:33+00:00 https://biolegacyresearch.com/fda-raps-ascend-therapeutics-for-misleading-estrogel-claims/ 2018-08-29T21:49:40+00:00 https://biolegacyresearch.com/fda-to-replace-guidance-on-developing-new-pain-drugs/ 2018-08-29T22:08:19+00:00 https://biolegacyresearch.com/indian-api-manufacturer-cited-for-investigative-deficiencies/ 2018-08-29T22:09:07+00:00 https://biolegacyresearch.com/fda-updates-investigation-on-valsartan-impurities-expands-recall/ 2018-08-30T20:36:59+00:00 https://biolegacyresearch.com/cms-part-d-plans-will-allow-indication-based-formularies-in-2020/ 2018-08-30T20:37:45+00:00 https://biolegacyresearch.com/eu-task-force-outlines-priorities-for-drug-shortage-prevention/ 2018-08-30T20:38:40+00:00 https://biolegacyresearch.com/court-blocks-sales-of-unapproved-sexual-enhancement-products/ 2018-08-30T21:59:37+00:00 https://biolegacyresearch.com/tga-calls-for-comments-on-boxed-warning-requirements/ 2018-09-04T19:03:28+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-targets-firms-for-quality-failures/ 2018-09-04T19:04:43+00:00 https://biolegacyresearch.com/483-roundup-three-facilities-slammed-for-various-deficiencies/ 2018-09-04T19:12:16+00:00 https://biolegacyresearch.com/fda-found-repeat-deficiencies-at-valsartan-manufacturers-facility/ 2018-09-04T19:13:54+00:00 https://biolegacyresearch.com/court-overturns-ruling-finding-gsk-liable-for-generic-users-suicide/ 2018-09-04T19:15:29+00:00 https://biolegacyresearch.com/westminster-recalls-thyroid-drugs-due-to-api-suppliers-deficiencies/ 2018-09-04T19:16:59+00:00 https://biolegacyresearch.com/stakeholders-seek-more-support-for-biosimilars/ 2018-09-04T21:40:59+00:00 https://biolegacyresearch.com/fda-issues-final-guidance-on-physiologically-based-pharmacokinetic-analyses/ 2018-09-04T21:42:00+00:00 https://biolegacyresearch.com/fda-may-hit-record-for-generic-approvals/ 2018-09-04T21:42:48+00:00 https://biolegacyresearch.com/fda-hits-malaysian-otc-manufacturer-for-multiple-deficiencies/ 2018-09-04T21:43:51+00:00 https://biolegacyresearch.com/fda-releases-final-guidance-on-drugs-for-hay-fever-non-allergic-rhinitis/ 2018-09-05T21:30:08+00:00 https://biolegacyresearch.com/fda-issues-new-manual-for-prioritizing-site-inspections/ 2018-09-05T21:30:56+00:00 https://biolegacyresearch.com/phrma-targets-hospitals-role-in-hiking-drug-costs/ 2018-09-05T21:31:43+00:00 https://biolegacyresearch.com/fda-cites-indian-manufacturer-for-training-record-deficiencies/ 2018-09-05T21:32:28+00:00 https://biolegacyresearch.com/ditta-urges-fda-to-fix-mdsap-inconsistencies/ 2018-09-06T20:37:04+00:00 https://biolegacyresearch.com/fda-to-allow-combo-products-to-submit-malfunction-summary-reports/ 2018-09-06T20:39:17+00:00 https://biolegacyresearch.com/fda-proposes-certain-device-accessories-be-defined-as-class-i/ 2018-09-06T20:42:38+00:00 https://biolegacyresearch.com/fda-pushes-back-udi-compliance-date-for-combination-products/ 2018-09-06T20:47:46+00:00 https://biolegacyresearch.com/tga-offers-new-guidance-on-electronic-instructions-for-use/ 2018-09-06T20:49:29+00:00 https://biolegacyresearch.com/health-canada-updates-requirements-for-class-ii-iii-infusion-pumps/ 2018-09-06T20:51:32+00:00 https://biolegacyresearch.com/sponsors-find-benefits-barriers-in-using-real-world-evidence/ 2018-09-06T20:54:58+00:00 https://biolegacyresearch.com/483-roundup-fda-flags-seven-firms-for-gmps/ 2018-09-06T20:58:40+00:00 https://biolegacyresearch.com/fda-warns-zimmer-biomet-for-quality-violations/ 2018-09-06T21:00:26+00:00 https://biolegacyresearch.com/health-canada-plans-3d-printing-guidance/ 2018-09-06T21:02:32+00:00 https://biolegacyresearch.com/senate-passes-bill-banning-pharmacy-gag-clauses/ 2018-09-06T21:24:58+00:00 https://biolegacyresearch.com/janssen-wins-lawsuit-alleging-risperdal-caused-weight-gain-diabetes/ 2018-09-06T21:25:57+00:00 https://biolegacyresearch.com/mccaskill-presses-hhs-on-efforts-to-curb-naloxones-rising-cost/ 2018-09-06T21:45:06+00:00 https://biolegacyresearch.com/maryland-ag-targets-insys-for-alleged-subsys-fraud/ 2018-09-07T20:18:41+00:00 https://biolegacyresearch.com/foundations-help-fund-nonprofit-generics-company/ 2018-09-07T20:19:34+00:00 https://biolegacyresearch.com/juno-to-settle-class-action-suit-over-clinical-trial-deaths/ 2018-09-07T20:20:40+00:00 https://biolegacyresearch.com/gottlieb-announces-revised-mou-on-interstate-distribution-of-compounded-drugs/ 2018-09-07T21:19:31+00:00 https://biolegacyresearch.com/fda-issues-guidance-on-postapproval-manufacturing-changes-for-synthetics/ 2018-09-10T21:18:12+00:00 https://biolegacyresearch.com/judge-dismisses-price-fixing-suit-against-impax-allows-amended-complaint/ 2018-09-10T21:19:01+00:00 https://biolegacyresearch.com/florida-pharmacist-convicted-of-5-million-compounding-fraud/ 2018-09-10T21:19:53+00:00 https://biolegacyresearch.com/fda-slams-mexican-manufacturer-for-numerous-violations/ 2018-09-10T21:20:42+00:00 https://biolegacyresearch.com/fda-proposes-removing-new-drug-approval-step-for-irradiated-otc-drugs/ 2018-09-11T21:49:34+00:00 https://biolegacyresearch.com/stakeholders-ask-fda-to-clarify-guidance-on-indications-and-usage-in-labeling/ 2018-09-11T21:50:25+00:00 https://biolegacyresearch.com/appeals-court-upholds-invalidity-of-acordas-ampyra-patents/ 2018-09-11T21:51:23+00:00 https://biolegacyresearch.com/canadian-manufacturer-draws-warning-for-sterility-issues/ 2018-09-11T21:52:10+00:00 https://biolegacyresearch.com/hospital-groups-sue-hhs-in-fight-for-340b-transparency/ 2018-09-12T21:44:14+00:00 https://biolegacyresearch.com/states-ask-appeals-court-to-rehear-st-regis-tribal-immunity-case/ 2018-09-12T21:45:08+00:00 https://biolegacyresearch.com/chinese-otc-drugmaker-warned-for-process-control-failures/ 2018-09-12T21:45:53+00:00 https://biolegacyresearch.com/nervous-system-drugs-lag-behind-in-development-approvals-tufts-reports/ 2018-09-12T22:05:38+00:00 https://biolegacyresearch.com/fda-offers-technical-specs-and-considerations-for-andas/ 2018-09-12T22:14:20+00:00 https://biolegacyresearch.com/fda-releases-product-specific-guidances-to-foster-generic-competition/ 2018-09-13T21:58:04+00:00 https://biolegacyresearch.com/fda-patient-experience-data-guidance-needs-labeling-details-drugmakers-say/ 2018-09-13T21:58:46+00:00 https://biolegacyresearch.com/half-of-eu-clinical-trial-results-are-not-reported/ 2018-09-13T21:59:45+00:00 https://biolegacyresearch.com/fda-discovers-second-impurity-in-chinese-manufacturers-valsartan/ 2018-09-13T22:00:37+00:00 https://biolegacyresearch.com/preclinical-cro/ 2018-09-13T22:23:44+00:00 https://biolegacyresearch.com/wp-content/uploads/2018/09/preclinical-CRO-1.jpg https://biolegacyresearch.com/gottlieb-announces-four-part-fda-plan-on-antimicrobial-resistance/ 2018-09-14T21:41:10+00:00 https://biolegacyresearch.com/fda-requests-comments-on-planned-503b-list-study/ 2018-09-14T21:42:48+00:00 https://biolegacyresearch.com/mccaskill-demands-explanation-for-nostrums-august-price-hikes/ 2018-09-14T21:43:41+00:00 https://biolegacyresearch.com/taiwanese-manufacturer-cited-for-multiple-violations/ 2018-09-14T21:44:30+00:00 https://biolegacyresearch.com/association-sues-new-york-for-taxing-opioid-makers/ 2018-09-17T21:13:32+00:00 https://biolegacyresearch.com/patient-groups-challenge-cvs-plan-to-deny-coverage-based-on-icer-cost-effectiveness/ 2018-09-17T21:14:43+00:00 https://biolegacyresearch.com/danish-api-maker-cited-for-sterility-violations/ 2018-09-17T21:16:03+00:00 https://biolegacyresearch.com/ema-seeks-comments-on-guidelines-for-neonate-products/ 2018-09-17T22:19:30+00:00 https://biolegacyresearch.com/senate-passes-bipartisan-opioid-crisis-relief-package/ 2018-09-17T23:16:00+00:00 https://biolegacyresearch.com/fda-suggests-endpoints-for-medicine-assisted-opioid-treatments/ 2018-09-18T21:52:01+00:00 https://biolegacyresearch.com/fda-issues-final-guidance-on-pbpk-analyses/ 2018-09-18T21:53:18+00:00 https://biolegacyresearch.com/two-drugmakers-ask-fda-to-lift-monotherapy-restrictions-for-mdd/ 2018-09-18T21:54:31+00:00 https://biolegacyresearch.com/fda-revises-mou-on-interstate-distribution-of-compounded-drugs/ 2018-09-18T21:57:55+00:00 https://biolegacyresearch.com/fda-adds-immediate-release-opioids-to-rems-to-expand-training-labeling/ 2018-09-18T22:22:23+00:00 https://biolegacyresearch.com/congress-targets-final-vote-on-reconciled-house-senate-opioid-bills-before-recess/ 2018-09-18T22:23:20+00:00 https://biolegacyresearch.com/senate-passes-bill-that-would-end-gag-clauses-for-insurers-pbms/ 2018-09-18T22:24:08+00:00 https://biolegacyresearch.com/fda-calls-out-dutch-manufacturer-for-storage-deficiencies/ 2018-09-18T22:25:18+00:00 https://biolegacyresearch.com/fda-issues-guidances-on-prescription-drug-identifier-requirements/ 2018-09-19T22:00:32+00:00 https://biolegacyresearch.com/fda-finalizes-guidance-for-labeling-testing-of-heparin-products/ 2018-09-19T22:02:35+00:00 https://biolegacyresearch.com/california-alleges-abbvie-paid-kickbacks-to-boost-humira-prescriptions/ 2018-09-19T22:03:03+00:00 https://biolegacyresearch.com/clovis-oncology-fined-20-million-for-misleading-efficacy-data/ 2018-09-19T22:04:33+00:00 https://biolegacyresearch.com/sponsors-who-dont-report-trial-data-could-be-hit-with-fines-fda-says/ 2018-09-20T21:51:58+00:00 https://biolegacyresearch.com/expert-committee-recommends-patient-focused-dissolution-standards/ 2018-09-20T21:52:46+00:00 https://biolegacyresearch.com/allergan-loses-bid-to-dismiss-restasis-antitrust-suit/ 2018-09-20T21:53:39+00:00 https://biolegacyresearch.com/ema-broadens-valsartan-contamination-investigation/ 2018-09-21T21:50:47+00:00 https://biolegacyresearch.com/drugmakers-say-fdas-far-guidance-contradicts-existing-regulations/ 2018-09-21T21:51:48+00:00 https://biolegacyresearch.com/brazilian-manufacturer-called-out-for-slew-of-violations/ 2018-09-21T21:52:40+00:00 https://biolegacyresearch.com/cbo-says-creates-act-would-save-over-3-billion/ 2018-09-21T21:57:29+00:00 https://biolegacyresearch.com/chmp-recommends-13-drugs-at-september-meeting/ 2018-09-21T22:14:32+00:00 https://biolegacyresearch.com/allergan-and-st-regis-mohawk-tribe-sue-amneal-over-generic-restasis-anda/ 2018-09-24T21:46:03+00:00 https://biolegacyresearch.com/drugmakers-seek-clarification-on-use-of-liquids-foods-as-drug-delivery-vehicles/ 2018-09-24T21:46:57+00:00 https://biolegacyresearch.com/new-fda-guidances-aim-to-reduce-number-of-review-cycles/ 2018-09-24T21:47:00+00:00 https://biolegacyresearch.com/fda-cites-buenos-aires-api-facility-for-records-equipment-calibration/ 2018-09-24T22:15:10+00:00 https://biolegacyresearch.com/phase-iii-trial-costs-estimated-at-19-million/ 2018-09-24T22:17:18+00:00 https://biolegacyresearch.com/gilead-to-launch-generics-for-its-hepatitis-c-drugs/ 2018-09-25T22:01:05+00:00 https://biolegacyresearch.com/ema-update-25-human-drugs-at-risk-of-brexit-supply-disruptions/ 2018-09-25T22:02:13+00:00 https://biolegacyresearch.com/fda-warns-indian-otc-facility-for-quality-violations/ 2018-09-25T22:03:36+00:00 https://biolegacyresearch.com/fda-releases-guidance-on-radiopharmaceutical-compounding-at-outsourcing-facilities/ 2018-09-25T22:10:29+00:00 https://biolegacyresearch.com/congress-advances-reconciled-opioid-crisis-package/ 2018-09-26T22:47:12+00:00 https://biolegacyresearch.com/branded-drugmakers-continue-to-hike-prices/ 2018-09-26T22:50:06+00:00 https://biolegacyresearch.com/arizona-outsourcing-facility-warned-for-misbranded-adulterated-products/ 2018-09-26T22:51:05+00:00 https://biolegacyresearch.com/indian-manufacturer-cited-for-cleaning-deficiencies-poor-complaint-handling/ 2018-09-26T22:52:10+00:00 https://biolegacyresearch.com/congress-sends-bills-banning-gag-clauses-to-presidents-desk/ 2018-09-27T23:35:04+00:00 https://biolegacyresearch.com/mylan-and-novartis-continue-to-push-back-against-fdas-biologics-suffixes/ 2018-09-27T23:35:51+00:00 https://biolegacyresearch.com/whistleblowers-allege-astrazeneca-paid-nurses-to-do-white-coat-marketing/ 2018-09-27T23:36:44+00:00 https://biolegacyresearch.com/fda-unveils-draft-guidances-on-innovative-trial-design/ 2018-09-28T22:30:37+00:00 https://biolegacyresearch.com/fda-releases-draft-guidance-on-threshold-analyses-and-human-factors-submissions/ 2018-09-28T22:31:23+00:00 https://biolegacyresearch.com/drug-companies-call-for-interchangeability-information-in-purple-book/ 2018-09-28T22:32:13+00:00 https://biolegacyresearch.com/fda-and-ema-hit-zhejiang-huahai-over-gmp-violations/ 2018-09-28T22:32:59+00:00 https://biolegacyresearch.com/generics-group-cries-foul-over-biosimilar-exclusivity-provision-in-usmca-trade-deal/ 2018-10-01T22:09:08+00:00 https://biolegacyresearch.com/report-brand-name-drug-prices-increased-faster-than-inflation/ 2018-10-01T22:10:00+00:00 https://biolegacyresearch.com/court-says-fresenius-can-pull-out-of-akorn-acquisition/ 2018-10-01T22:11:06+00:00 https://biolegacyresearch.com/taiwanese-api-manufacturer-hit-for-sanitization-issues/ 2018-10-01T22:11:48+00:00 https://biolegacyresearch.com/pharma-companies-in-san-diego/ 2018-10-02T18:59:37+00:00 https://biolegacyresearch.com/wp-content/uploads/2018/10/pharma.jpg https://biolegacyresearch.com/warning-letter-roundup-four-facilities-cited-for-procedural-failures/ 2018-10-02T21:59:59+00:00 https://biolegacyresearch.com/fda-issues-prescription-drug-identifier-guidances/ 2018-10-02T22:06:48+00:00 https://biolegacyresearch.com/483-roundup-fda-hits-foreign-manufacturers-for-quality-issues/ 2018-10-02T22:08:08+00:00 https://biolegacyresearch.com/fda-releases-guidance-on-radiopharmaceutical-compounding/ 2018-10-02T22:11:18+00:00 https://biolegacyresearch.com/fda-may-remove-new-drug-approval-step-for-irradiated-otc-drugs/ 2018-10-02T22:12:40+00:00 https://biolegacyresearch.com/oig-fda-needs-to-better-integrate-cybersecurity-into-device-reviews/ 2018-10-04T20:35:52+00:00 https://biolegacyresearch.com/fda-gives-feedback-to-congress-on-new-diagnostics-standards/ 2018-10-04T20:38:28+00:00 https://biolegacyresearch.com/fda-says-medtronic-facilities-must-undergo-followup-inspections/ 2018-10-04T20:40:03+00:00 https://biolegacyresearch.com/fda-warns-itg-medev-for-validations-other-failures/ 2018-10-04T20:41:51+00:00 https://biolegacyresearch.com/fda-proposed-rule-would-simplify-premarket-device-submissions/ 2018-10-04T20:44:02+00:00 https://biolegacyresearch.com/fda-warns-devicemakers-over-pen-needles/ 2018-10-04T20:45:49+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-six-firms-for-quality-gmp-violations/ 2018-10-04T20:47:33+00:00 https://biolegacyresearch.com/devicemakers-critical-of-fda-test-methods-for-metal-biliary-stent-pmas/ 2018-10-04T20:49:47+00:00 https://biolegacyresearch.com/gottlieb-announces-revised-mou-on-distribution-of-compounded-drugs/ 2018-10-10T20:16:02+00:00 https://biolegacyresearch.com/whistleblowers-allege-astrazeneca-paid-for-white-coat-marketing/ 2018-10-10T20:20:45+00:00 https://biolegacyresearch.com/nervous-system-drugs-lag-in-development-approvals-tufts/ 2018-10-10T20:22:12+00:00 https://biolegacyresearch.com/fda-issues-guidance-on-postapproval-changes-for-synthetics/ 2018-10-10T20:28:27+00:00 https://biolegacyresearch.com/mhra-seeks-industry-input-on-no-deal-brexit-provisions/ 2018-10-10T20:32:40+00:00 https://biolegacyresearch.com/federal-court-echoes-ptab-ruling-invalidating-zytiga-patent/ 2018-10-30T22:11:01+00:00 https://biolegacyresearch.com/nebraska-drugmaker-cited-for-lacking-quality-unit/ 2018-10-30T22:11:49+00:00 https://biolegacyresearch.com/appeals-court-affirms-fda-on-denial-of-prescription-generics-for-bayer-laxative/ 2018-11-01T00:00:10+00:00 https://biolegacyresearch.com/former-genentech-employees-charged-with-theft-of-trade-secrets/ 2018-11-01T00:01:40+00:00 https://biolegacyresearch.com/fda-cites-vanda-for-misleading-website/ 2018-11-01T00:02:32+00:00 https://biolegacyresearch.com/fda-warns-customrx-facility-for-cleanroom-potency-testing/ 2018-11-01T00:07:46+00:00 https://biolegacyresearch.com/fda-warns-becton-dickinson-over-water-environmental-conditions/ 2018-11-08T20:25:29+00:00 https://biolegacyresearch.com/allergan-recalls-implant-in-eu-for-loose-silicone-particle/ 2018-11-08T20:27:25+00:00 https://biolegacyresearch.com/483-roundup-fda-flags-firms-for-mdrs-other-failures/ 2018-11-08T20:28:27+00:00 https://biolegacyresearch.com/european-commission-clarifies-udi-obligations-under-new-regs/ 2018-11-08T20:30:31+00:00 https://biolegacyresearch.com/fda-issues-cybersecurity-warning-for-cardiac-device-programmers/ 2018-11-08T20:31:24+00:00 https://biolegacyresearch.com/fda-issues-new-classification-for-implantable-hearing-system/ 2018-11-08T20:32:17+00:00 https://biolegacyresearch.com/fda-classifies-humidified-oxygen-devices-assigns-special-controls/ 2018-11-08T20:33:09+00:00 https://biolegacyresearch.com/senators-question-digital-health-pre-cert-program/ 2018-11-08T20:34:02+00:00 https://biolegacyresearch.com/fda-and-dhs-expand-cooperation-to-ensure-device-cybersecurity/ 2018-11-08T20:35:14+00:00 https://biolegacyresearch.com/fda-guidance-revises-packaging-terms-for-injectable-medical-products/ 2018-11-08T21:25:41+00:00 https://biolegacyresearch.com/fda-releases-list-of-upcoming-rulemakings/ 2018-11-08T21:27:26+00:00 https://biolegacyresearch.com/warning-letter-roundup-facilities-slammed-for-cgmp-violations/ 2018-11-08T21:29:30+00:00 https://biolegacyresearch.com/fda-guidance-explains-verification-systems-for-certain-drugs/ 2018-11-08T21:30:58+00:00 https://biolegacyresearch.com/otc-drugmaker-in-tennessee-hit-with-consent-decree/ 2018-11-08T21:32:18+00:00 https://biolegacyresearch.com/ema-enters-new-phase-of-brexit-preparations/ 2018-11-08T21:33:43+00:00 https://biolegacyresearch.com/fda-and-ema-take-action-against-zhejiang-huahai-over-gmp-violations/ 2018-11-08T21:35:19+00:00 https://biolegacyresearch.com/hatch-bennet-introduce-bill-to-update-labeling-standards/ 2018-11-08T21:36:31+00:00 https://biolegacyresearch.com/483-roundup-fda-calls-out-four-firms-over-testing-sanitation/ 2018-11-08T21:38:21+00:00 https://biolegacyresearch.com/chmp-recommends-six-medicines-for-approval/ 2018-11-19T18:03:47+00:00 https://biolegacyresearch.com/fda-drops-proposal-requiring-sponsors-to-report-falsified-data/ 2018-11-19T18:06:32+00:00 https://biolegacyresearch.com/fda-guidance-clarifies-agency-regs-v-revised-common-rule/ 2018-11-19T18:08:16+00:00 https://biolegacyresearch.com/phrma-updates-tv-ad-guidelines-ahead-of-dtc-price-disclosure/ 2018-11-19T18:10:25+00:00 https://biolegacyresearch.com/trump-signs-legislation-banning-gag-orders-for-pharmacists/ 2018-11-19T18:12:17+00:00 https://biolegacyresearch.com/appeals-court-upholds-ptab-ruling-in-favor-of-biogens-ms-patent/ 2018-11-19T18:13:43+00:00 https://biolegacyresearch.com/drugmakers-dispute-scope-of-orphan-drug-exclusivity/ 2018-11-19T18:15:26+00:00 https://biolegacyresearch.com/boehringer-wins-third-bellwether-suit-over-its-blood-thinner/ 2018-11-19T18:16:44+00:00 https://biolegacyresearch.com/kentucky-ag-sues-teva-for-promoting-off-label-uses-of-fentanyl-products/ 2018-11-19T18:18:01+00:00 https://biolegacyresearch.com/bts-research-appoints-mark-crane-as-vice-president-business-development/ 2018-11-19T20:25:59+00:00 https://biolegacyresearch.com/bts-researchs-sam-abunadi-president-ceo-urges-the-fda-to-require-clinical-trials-for-cannabis-dose-determination-as-a-scheduled-substance-with-not-yet-classified-strands/ 2018-11-27T21:00:13+00:00 https://biolegacyresearch.com/ags-ask-supreme-court-to-affirm-states-power-to-sue-drugmakers-over-misleading-labeling/ 2018-11-29T21:24:28+00:00 https://biolegacyresearch.com/u-s-eu-partnership-on-gmp-inspections-adds-five-countries/ 2018-11-29T21:25:18+00:00 https://biolegacyresearch.com/who-considers-ways-to-boost-access-cut-prices-for-cancer-drugs/ 2018-11-30T22:57:00+00:00 https://biolegacyresearch.com/fda-who-unveil-pilot-program-for-faster-hiv-drug-reviews/ 2018-11-30T23:04:00+00:00 https://biolegacyresearch.com/sen-merkley-proposes-bill-linking-drug-prices-with-healthcare-access/ 2018-11-30T23:08:55+00:00 https://biolegacyresearch.com/massachusetts-u-s-attorney-warns-opioid-prescribers-whose-patients-died/ 2018-11-30T23:17:33+00:00 https://biolegacyresearch.com/gao-urges-fda-to-improve-orphan-drug-reviews/ 2018-11-30T23:36:31+00:00 https://biolegacyresearch.com/advanced-nhp-research-capabilities-molecular-imaging/ 2018-12-03T19:30:10+00:00 https://biolegacyresearch.com/wp-content/uploads/2018/12/biolarus.png https://biolegacyresearch.com/wp-content/uploads/2018/12/pdf.png https://biolegacyresearch.com/fda-moves-to-modernize-inspections-for-sterile-injectables/ 2018-12-03T20:56:06+00:00 https://biolegacyresearch.com/ema-invites-comments-on-water-quality-guideline-for-drugmakers/ 2018-12-03T21:00:12+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-warns-five-firms-over-cgmps/ 2018-12-03T21:04:34+00:00 https://biolegacyresearch.com/aam-questions-fdas-product-identifiers-in-supply-chain-guidance/ 2018-12-03T21:06:00+00:00 https://biolegacyresearch.com/fda-turns-down-testosterone-pellet-petition/ 2018-12-03T21:11:01+00:00 https://biolegacyresearch.com/483-roundup-fda-flags-eight-firms-for-quality-issues/ 2018-12-03T21:24:26+00:00 https://biolegacyresearch.com/fda-extends-udi-deadlines-another-two-years-for-class-i-unclassified-devices/ 2018-12-06T21:10:49+00:00 https://biolegacyresearch.com/cdrh-posts-new-timeline-update-on-medical-device-testing-accreditation-pilot/ 2018-12-06T21:12:52+00:00 https://biolegacyresearch.com/warning-letter-roundup-three-firms-cited-for-adulterated-devices/ 2018-12-06T21:14:09+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-firms-for-quality-risk-analysis-and-sops/ 2018-12-06T21:17:51+00:00 https://biolegacyresearch.com/fda-issues-updated-medical-device-safety-action-plan/ 2018-12-06T21:19:23+00:00 https://biolegacyresearch.com/fda-issues-updates-on-overheating-problems-in-mr-guided-lasers/ 2018-12-06T21:21:22+00:00 https://biolegacyresearch.com/fda-reconsiders-electronic-labeling-for-certain-devices/ 2018-12-06T21:22:00+00:00 https://biolegacyresearch.com/fda-releases-draft-guidances-on-blood-glucose-monitors/ 2018-12-06T21:23:54+00:00 https://biolegacyresearch.com/who-finds-wide-variations-in-antibiotic-use/ 2018-12-13T22:39:02+00:00 https://biolegacyresearch.com/pharma-group-calls-for-more-incentives-for-antibiotic-research/ 2018-12-13T22:39:26+00:00 https://biolegacyresearch.com/gottlieb-highlights-commitment-to-expanded-access-to-trials/ 2018-12-13T22:39:49+00:00 https://biolegacyresearch.com/drug-safety-there-should-be-an-app-for-that-fda-says/ 2018-12-13T22:40:55+00:00 https://biolegacyresearch.com/fda-holds-sponsors-accountable-for-post-marketing-studies/ 2018-12-13T22:42:00+00:00 https://biolegacyresearch.com/fda-parries-on-teva-180-day-exclusivity-suit/ 2018-12-13T22:42:01+00:00 https://biolegacyresearch.com/fda-issues-guidance-for-combination-hypertension-drugs/ 2018-12-13T22:43:04+00:00 https://biolegacyresearch.com/pfizer-loses-lyrica-patent-battle-in-uk-supreme-court/ 2018-12-13T22:43:28+00:00 https://biolegacyresearch.com/ema-considers-ways-to-evaluate-non-genotoxic-drug-impurities/ 2018-12-13T22:44:01+00:00 https://biolegacyresearch.com/canada-clears-three-drugmakers-of-blocking-generic-competitors/ 2018-12-27T00:00:00+00:00 https://biolegacyresearch.com/fda-denies-pmrs-petition-to-deny-chronic-use-opioid-ndas/ 2018-12-27T23:00:00+00:00 https://biolegacyresearch.com/ex-insys-ceo-to-plead-guilty-of-role-in-subsys-bribery-scheme/ 2018-12-27T23:00:00+00:00 https://biolegacyresearch.com/ema-seeks-comments-on-rare-allergy-trials/ 2018-12-27T23:00:00+00:00 https://biolegacyresearch.com/shutdown-enters-day-seven-with-no-sign-of-a-breakthrough/ 2018-12-27T23:00:00+00:00 https://biolegacyresearch.com/bts-research-passed-usda-inspection-2018/ 2018-12-28T21:37:44+00:00 https://biolegacyresearch.com/fda-pulls-rule-allowing-independent-updates-to-generic-drug-labeling/ 2019-01-08T22:32:48+00:00 https://biolegacyresearch.com/fda-hits-zhejiang-huahai-for-contamination-investigation/ 2019-01-08T22:33:18+00:00 https://biolegacyresearch.com/indian-drugmaker-warned-after-refusing-fda-inspection/ 2019-01-08T22:33:42+00:00 https://biolegacyresearch.com/lawsuit-walmart-drugmaker-sold-contaminated-drugs/ 2019-01-08T22:34:06+00:00 https://biolegacyresearch.com/korean-manufacturer-warned-for-quality-control-drug-storage/ 2019-01-08T22:34:31+00:00 https://biolegacyresearch.com/indian-api-manufacturer-cited-for-complaint-handling-batch-records/ 2019-01-08T22:34:54+00:00 https://biolegacyresearch.com/canadian-drug-facility-cited-for-contamination-risks/ 2019-01-08T22:35:18+00:00 https://biolegacyresearch.com/fda-hits-connecticut-sterile-drugmaker-for-mold-contamination/ 2019-01-08T22:35:49+00:00 https://biolegacyresearch.com/gottlieb-fda-will-increase-inspections-of-stem-cell-facilities/ 2019-01-08T22:36:14+00:00 https://biolegacyresearch.com/fda-partially-grants-petition-for-hypnotic-drug-labeling/ 2019-01-08T22:36:38+00:00 https://biolegacyresearch.com/tga-offers-guidance-on-regulating-software-as-a-medical-device/ 2019-01-11T21:50:54+00:00 https://biolegacyresearch.com/jj-in-400-million-settlement-over-faulty-hip-replacements/ 2019-01-11T21:52:16+00:00 https://biolegacyresearch.com/fda-warns-mibo-medical-for-design-controls-capas/ 2019-01-11T21:53:56+00:00 https://biolegacyresearch.com/fda-unveils-guidance-on-diagnostic-x-ray-equipment/ 2019-01-11T21:54:28+00:00 https://biolegacyresearch.com/device-groups-reject-media-reports-of-inadequate-oversight/ 2019-01-11T21:55:02+00:00 https://biolegacyresearch.com/canada-issues-guidance-on-cybersecurity-requirements/ 2019-01-11T21:58:29+00:00 https://biolegacyresearch.com/texas-neonatal-devicemaker-falls-short-on-process-controls/ 2019-01-11T21:59:02+00:00 https://biolegacyresearch.com/surgical-instruments-maker-racks-up-11-item-483/ 2019-01-11T21:59:59+00:00 https://biolegacyresearch.com/controls-found-lacking-at-contract-manufacturer-thatcher/ 2019-01-11T22:00:41+00:00 https://biolegacyresearch.com/gottlieb-touts-fdas-plans-for-real-world-evidence-in-trials/ 2019-01-28T22:56:22+00:00 https://biolegacyresearch.com/phrma-pushes-back-on-cms-plan-to-increase-medicare-part-d-advantage-negotiating-power/ 2019-01-28T22:57:26+00:00 https://biolegacyresearch.com/ny-pharmacists-pbms-hiked-generics-prices-in-medicaid-managed-care-program/ 2019-01-28T22:58:17+00:00 https://biolegacyresearch.com/pharma-blasted-in-congress-for-manipulating-drug-prices/ 2019-01-29T23:19:59+00:00 https://biolegacyresearch.com/pcma-says-competition-is-key-to-lowering-drug-prices/ 2019-01-29T23:21:14+00:00 https://biolegacyresearch.com/fda-extends-type-iii-drug-master-file-e-submission-compliance-date-another-year/ 2019-01-29T23:22:46+00:00 https://biolegacyresearch.com/fda-warns-chinese-otc-drugmaker/ 2019-01-29T23:23:37+00:00 https://biolegacyresearch.com/shutdown-that-curtailed-some-fda-inspections-ends-for-now/ 2019-02-05T21:56:32+00:00 https://biolegacyresearch.com/fda-shares-new-findings-in-valsartan-investigation/ 2019-02-05T21:58:01+00:00 https://biolegacyresearch.com/fda-issues-new-guidance-on-assessing-rems/ 2019-02-05T22:00:12+00:00 https://biolegacyresearch.com/fda-denies-petition-to-add-warning-to-blood-thinner-labeling/ 2019-02-05T22:02:00+00:00 https://biolegacyresearch.com/fda-warns-akorn-over-conditions-at-sterile-drug-facility/ 2019-02-05T22:04:21+00:00 https://biolegacyresearch.com/483-roundup-fda-flags-seven-firms-for-testing-other-issues/ 2019-02-05T22:09:27+00:00 https://biolegacyresearch.com/italian-agency-hits-chinese-heparin-manufacturer-for-gmp-violations/ 2019-02-05T22:12:49+00:00 https://biolegacyresearch.com/fda-releases-naloxone-drug-facts-labels-to-spur-otc-development/ 2019-02-05T22:15:20+00:00 https://biolegacyresearch.com/ema-considers-electronic-product-information-standard-for-drugs/ 2019-02-05T22:17:59+00:00 https://biolegacyresearch.com/notified-bodies-warn-of-future-bottlenecks-in-implementing-new-device-regs/ 2019-02-08T19:10:24+00:00 https://biolegacyresearch.com/health-canada-maps-out-action-plan-to-improve-device-safety-quality/ 2019-02-08T19:13:02+00:00 https://biolegacyresearch.com/cdrh-seeks-stakeholder-input-on-2019-guidance-priorities/ 2019-02-08T19:15:04+00:00 https://biolegacyresearch.com/hscc-introduces-plan-for-cybersecurity-by-design/ 2019-02-08T19:16:46+00:00 https://biolegacyresearch.com/china-introduces-routine-overseas-device-inspections/ 2019-02-08T19:18:35+00:00 https://biolegacyresearch.com/fda-cites-six-firms-for-gmp-other-issues/ 2019-02-08T19:21:45+00:00 https://biolegacyresearch.com/bsi-warns-devicemakers-to-migrate-ce-certificates-before-brexit-deadline/ 2019-02-08T19:26:13+00:00 https://biolegacyresearch.com/novartis-considers-appealing-1-5-million-whistleblower-verdict/ 2019-02-27T22:52:40+00:00 https://biolegacyresearch.com/ftcs-shire-appeal-denied-in-fight-over-citizen-petitions/ 2019-02-27T22:53:34+00:00 https://biolegacyresearch.com/spanish-otc-drugmaker-nailed-for-testing-records/ 2019-02-27T22:54:16+00:00 https://biolegacyresearch.com/ogd-reports-continued-increase-in-first-time-generic-approvals-in-2018/ 2019-02-28T22:59:22+00:00 https://biolegacyresearch.com/fda-warns-canarx-over-drug-distribution-scheme/ 2019-02-28T23:00:26+00:00 https://biolegacyresearch.com/judge-throws-out-teva-lawsuit-against-fda-generic-exclusivity-policy/ 2019-02-28T23:01:40+00:00 https://biolegacyresearch.com/fda-proposes-voluntary-consensus-standards-to-help-speed-drug-reviews/ 2019-03-05T22:14:19+00:00 https://biolegacyresearch.com/fda-increases-efforts-to-flag-public-warnings-recalls/ 2019-03-05T22:15:35+00:00 https://biolegacyresearch.com/fda-says-505q-petitions-pull-resources-from-safety-activities/ 2019-03-05T22:17:24+00:00 https://biolegacyresearch.com/fda-issues-five-warning-letters-citing-cgmp-violations-insanitary-conditions/ 2019-03-05T22:19:02+00:00 https://biolegacyresearch.com/three-drugmakers-draw-fda-reprimands-for-quality-failures/ 2019-03-05T22:20:40+00:00 https://biolegacyresearch.com/gottlieb-updates-lawmakers-on-plans-to-expand-faers/ 2019-03-05T22:22:05+00:00 https://biolegacyresearch.com/stakeholders-call-on-fda-to-clarify-supply-chain-verification-guidance/ 2019-03-05T22:23:14+00:00 https://biolegacyresearch.com/fda-warns-17-companies-over-unapproved-alzheimers-drugs/ 2019-03-05T22:24:37+00:00 https://biolegacyresearch.com/mckesson-draws-fdas-first-dscsa-related-warning-letter/ 2019-03-05T22:25:55+00:00 https://biolegacyresearch.com/tga-issues-draft-guidance-on-regulations-for-personalized-devices/ 2019-03-08T20:20:05+00:00 https://biolegacyresearch.com/fda-warns-total-thermal-imaging-for-unapproved-screening-device/ 2019-03-08T20:25:00+00:00 https://biolegacyresearch.com/massachusetts-devicemaker-hit-for-discrepancy-investigation-reports/ 2019-03-08T20:27:04+00:00 https://biolegacyresearch.com/imaging-biometrics-cited-for-complaint-investigation-records/ 2019-03-08T20:29:09+00:00 https://biolegacyresearch.com/tga-proposes-overhaul-for-samd-personalized-devices/ 2019-03-08T20:31:01+00:00 https://biolegacyresearch.com/sarstedt-called-out-for-inadequate-documentation/ 2019-03-08T20:32:54+00:00 https://biolegacyresearch.com/fda-to-exempt-unclassified-devices-from-premarket-notification/ 2019-03-08T20:34:00+00:00 https://biolegacyresearch.com/fda-increases-efforts-to-flag-recalls/ 2019-03-08T20:37:38+00:00 https://biolegacyresearch.com/ema-issues-guidance-on-new-device-ivd-rules/ 2019-03-08T20:43:45+00:00 https://biolegacyresearch.com/fda-announces-2019-initiatives-for-device-safety-and-innovation/ 2019-03-08T20:45:36+00:00 https://biolegacyresearch.com/gottlieb-highlights-fda-efforts-on-opioids-in-senate-testimony/ 2019-03-28T21:30:27+00:00 https://biolegacyresearch.com/new-york-files-detailed-suit-against-opioid-makers-distributors/ 2019-03-28T21:31:17+00:00 https://biolegacyresearch.com/ema-reviews-two-decades-of-drug-inspections/ 2019-03-28T21:49:24+00:00 https://biolegacyresearch.com/gottlieb-urges-drug-sponsors-to-expand-access-to-treatment-after-trials/ 2019-03-29T21:51:36+00:00 https://biolegacyresearch.com/brexit-chaos-has-drug-regulators-industry-living-in-conditional-tense/ 2019-03-29T21:52:26+00:00 https://biolegacyresearch.com/fda-warns-california-otc-drugmaker-for-defective-products/ 2019-03-29T21:53:09+00:00 https://biolegacyresearch.com/oklahoma-otc-manufacturer-cited-for-multiple-violations/ 2019-03-29T21:53:57+00:00 https://biolegacyresearch.com/cder-lists-planned-guidances-for-2019/ 2019-04-01T18:24:54+00:00 https://biolegacyresearch.com/tga-lists-pharmacovigilance-deficiencies-in-first-inspection-metrics-report/ 2019-04-01T18:27:46+00:00 https://biolegacyresearch.com/fda-lays-out-final-rules-for-pediatric-labeling/ 2019-04-01T18:30:04+00:00 https://biolegacyresearch.com/warning-letter-roundup-five-firms-warned-for-serious-violations/ 2019-04-01T18:31:36+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-five-drugmakers-for-gmps-other-issues/ 2019-04-01T18:34:41+00:00 https://biolegacyresearch.com/mhra-issues-guidance-for-air-shipping-medicines-in-no-deal-brexit/ 2019-04-01T18:47:40+00:00 https://biolegacyresearch.com/fda-proposes-total-product-lifecycle-approach-to-ai-devices/ 2019-04-05T15:58:32+00:00 https://biolegacyresearch.com/fda-warns-two-breast-implant-makers-over-post-approval-studies/ 2019-04-05T15:59:27+00:00 https://biolegacyresearch.com/fda-moves-to-improve-mammography-quality-standards/ 2019-04-05T16:00:21+00:00 https://biolegacyresearch.com/tga-ends-three-year-transition-to-iso-134852016/ 2019-04-05T16:01:15+00:00 https://biolegacyresearch.com/483-roundup-six-device-firms-cited-for-gmp-other-failures/ 2019-04-05T16:02:16+00:00 https://biolegacyresearch.com/mita-urges-fda-to-clarify-servicing-and-remanufacturing-differences/ 2019-04-05T16:03:22+00:00 https://biolegacyresearch.com/fda-lays-out-new-guidance-on-anthrax-testing-devices/ 2019-04-05T16:04:15+00:00 https://biolegacyresearch.com/ec-issues-guidance-on-eudamed-nomenclature-system/ 2019-04-05T16:05:15+00:00 https://biolegacyresearch.com/cdrh-warns-of-device-shortages-following-sterilizers-suspension/ 2019-04-05T16:06:13+00:00 https://biolegacyresearch.com/australia-proposes-new-device-classifications-to-align-with-eu-regs/ 2019-04-05T16:07:25+00:00 https://biolegacyresearch.com/cincinnati-drugmaker-cited-for-quality-equipment-concerns/ 2019-04-26T21:26:00+00:00 https://biolegacyresearch.com/who-issues-urgent-call-for-new-drugs-to-fight-superbugs/ 2019-04-29T21:26:17+00:00 https://biolegacyresearch.com/washington-awards-abbvie-nations-second-netflix-hep-c-contract/ 2019-04-29T21:27:03+00:00 https://biolegacyresearch.com/chmp-recommends-13-new-drugs-for-approval-including-two-orphan-meds/ 2019-04-29T21:27:57+00:00 https://biolegacyresearch.com/minnesota-drugmaker-cited-for-cleaning-deficiencies/ 2019-04-29T21:28:55+00:00 https://biolegacyresearch.com/european-commission-releases-details-on-eudamed-nomenclature-system/ 2019-05-03T20:40:54+00:00 https://biolegacyresearch.com/fda-addresses-safety-concerns-for-surgical-staplers-and-staples/ 2019-05-03T20:42:12+00:00 https://biolegacyresearch.com/483-roundup-fda-flags-three-firms-for-quality-other-issues/ 2019-05-03T20:43:31+00:00 https://biolegacyresearch.com/cdrh-flags-ongoing-concerns-over-contaminated-duodenoscopes/ 2019-05-03T20:46:17+00:00 https://biolegacyresearch.com/fda-issues-final-guidance-on-bench-performance-testing/ 2019-05-03T20:49:00+00:00 https://biolegacyresearch.com/combination-products-get-extra-year-for-postmarket-safety-compliance/ 2019-05-03T20:50:23+00:00 https://biolegacyresearch.com/fda-clarifies-labeling-identifier-rules-for-convenience-kits/ 2019-05-03T20:51:45+00:00 https://biolegacyresearch.com/fda-issues-list-of-class-1-accessories/ 2019-05-03T20:52:58+00:00 https://biolegacyresearch.com/fda-scraps-biannual-biologics-inspections-for-risk-based-approach/ 2019-05-06T21:20:09+00:00 https://biolegacyresearch.com/fda-urged-to-clarify-voluntary-quality-standards-for-combination-products/ 2019-05-06T21:20:32+00:00 https://biolegacyresearch.com/fda-issues-draft-guidance-for-handling-recalls/ 2019-05-06T21:20:54+00:00 https://biolegacyresearch.com/warning-letter-roundup-four-companies-hit-for-gmp-violations/ 2019-05-06T21:21:22+00:00 https://biolegacyresearch.com/483-roundup-four-drugmakers-cited-over-quality-problems/ 2019-05-06T21:21:53+00:00 https://biolegacyresearch.com/european-parliament-evens-scales-for-generics-makers-with-new-waivers/ 2019-05-06T21:22:21+00:00 https://biolegacyresearch.com/gottlieb-features-compounding-in-farewell-congressional-testimony/ 2019-05-06T21:23:07+00:00 https://biolegacyresearch.com/fda-hits-texas-drug-facility-for-oversight-of-pilot-exhibit-batches/ 2019-05-28T21:16:26+00:00 https://biolegacyresearch.com/novartis-wonder-drug-comes-at-wondrous-price/ 2019-05-29T21:55:27+00:00 https://biolegacyresearch.com/chmp-gives-thumbs-down-to-sickle-cell-treatment/ 2019-05-29T21:56:12+00:00 https://biolegacyresearch.com/australia-hikes-gmp-clearance-fees/ 2019-05-29T21:57:53+00:00 https://biolegacyresearch.com/italian-medicines-agency-nails-drugmaker-for-major-deficiencies/ 2019-05-29T21:58:44+00:00 https://biolegacyresearch.com/who-calls-for-gmps-to-limit-wastewater-driven-superbugs/ 2019-06-04T20:47:27+00:00 https://biolegacyresearch.com/italian-medicines-agency-hits-drugmaker-for-major-deficiencies/ 2019-06-04T20:50:34+00:00 https://biolegacyresearch.com/canada-details-new-user-fees-for-drug-sponsors/ 2019-06-04T20:52:01+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-warns-five-firms-for-quality-gmps/ 2019-06-04T20:53:18+00:00 https://biolegacyresearch.com/judge-enters-consent-decree-against-texas-compounder/ 2019-06-04T20:54:46+00:00 https://biolegacyresearch.com/illinois-compounder-hit-with-consent-decree-over-violations-at-multiple-sites/ 2019-06-04T20:56:04+00:00 https://biolegacyresearch.com/ex-fda-investigator-blows-whistle-on-fdas-handling-of-foreign-inspections/ 2019-06-04T20:57:30+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-five-firms-for-quality-other-violations/ 2019-06-04T20:58:52+00:00 https://biolegacyresearch.com/health-canada-issues-final-guidance-on-3d-printed-implantable-devices/ 2019-06-07T15:04:07+00:00 https://biolegacyresearch.com/european-commission-clarifies-what-udi-info-is-needed-for-eudamed/ 2019-06-07T15:05:40+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-flags-four-firms-for-quality/ 2019-06-07T15:07:25+00:00 https://biolegacyresearch.com/sloppy-validation-complaint-handling-found-at-duke-empirical/ 2019-06-07T15:08:58+00:00 https://biolegacyresearch.com/singapore-diagnostics-maker-fails-to-establish-sops-for-investigations/ 2019-06-07T15:10:59+00:00 https://biolegacyresearch.com/phototherapy-developer-amiss-on-capa-supplier-audits/ 2019-06-07T15:12:33+00:00 https://biolegacyresearch.com/fda-issues-alert-for-beckman-coulter-blood-analyzers/ 2019-06-07T15:13:50+00:00 https://biolegacyresearch.com/senator-demands-answers-from-companies-over-duodenoscopes/ 2019-06-07T15:15:07+00:00 https://biolegacyresearch.com/canada-details-new-user-fees-for-devices/ 2019-06-07T15:16:50+00:00 https://biolegacyresearch.com/fda-considers-how-heart-patients-feel-function-in-new-draft-guidance/ 2019-06-27T21:23:15+00:00 https://biolegacyresearch.com/fda-proposes-new-rule-formalizing-master-files-for-blas/ 2019-06-27T21:24:11+00:00 https://biolegacyresearch.com/cber-flags-planned-gene-therapy-guidances-for-2019/ 2019-06-27T21:25:15+00:00 https://biolegacyresearch.com/pfizer-bags-a-new-biosimilar-and-a-former-commissioner/ 2019-06-28T21:39:33+00:00 https://biolegacyresearch.com/fda-issues-guidance-on-developing-drugs-to-treat-epidermolysis-bullosa/ 2019-06-28T21:42:10+00:00 https://biolegacyresearch.com/congress-seeks-gao-review-of-foreign-drug-inspection-program/ 2019-06-28T21:43:38+00:00 https://biolegacyresearch.com/glenmark-draws-complete-response-letter-for-allergy-spray/ 2019-06-28T21:44:41+00:00 https://biolegacyresearch.com/house-appropriations-pushes-fda-on-continuous-manufacturing/ 2019-07-09T21:08:19+00:00 https://biolegacyresearch.com/cders-office-of-compliance-to-lead-compounder-regulation/ 2019-07-09T21:09:43+00:00 https://biolegacyresearch.com/fda-criticizes-california-drugmaker-for-prescription-diet-pill-claims/ 2019-07-09T21:11:36+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-scolds-drugmakers-for-quality-violations/ 2019-07-09T21:14:28+00:00 https://biolegacyresearch.com/fda-gives-gentle-nudge-to-industry-on-stem-cells/ 2019-07-09T21:15:58+00:00 https://biolegacyresearch.com/fda-puts-together-supergroup-for-track-and-trace-pilot/ 2019-07-09T21:18:28+00:00 https://biolegacyresearch.com/aclaris-snags-untitled-letter-for-misleading-statements-in-tv-ad/ 2019-07-09T21:20:04+00:00 https://biolegacyresearch.com/australia-updates-gmp-clearance-guidance-with-processing-times/ 2019-07-09T21:21:38+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-four-drugmakers-for-serious-violations/ 2019-07-09T21:23:19+00:00 https://biolegacyresearch.com/fda-data-chief-urges-drugmakers-to-sign-up-for-quality-metrics-programs/ 2019-07-11T22:21:58+00:00 https://biolegacyresearch.com/more-notified-bodies-give-up-on-eu-mdr-ivd-certification/ 2019-07-11T22:22:44+00:00 https://biolegacyresearch.com/gs1-issues-new-guidelines-that-reflect-new-udi-requirements/ 2019-07-11T22:23:42+00:00 https://biolegacyresearch.com/devicemakers-comment-on-machine-learning-for-samd/ 2019-07-11T22:25:08+00:00 https://biolegacyresearch.com/483-roundup-fda-flags-four-firms-for-gmps-quality/ 2019-07-11T22:27:07+00:00 https://biolegacyresearch.com/part-806-reports-when-to-submit-them-and-how-to-avoid-pitfalls/ 2019-07-11T22:28:49+00:00 https://biolegacyresearch.com/ec-releases-new-guidance-on-data-exchange-options/ 2019-07-11T22:29:50+00:00 https://biolegacyresearch.com/senate-finance-committees-bipartisan-drug-pricing-bill-advances/ 2019-07-25T21:44:42+00:00 https://biolegacyresearch.com/fda-warns-india-based-indoco-for-data-integrity-concerns/ 2019-07-25T21:48:35+00:00 https://biolegacyresearch.com/fda-oks-boxed-warning-for-pfizers-xeljanz-following-serious-safety-concerns/ 2019-07-26T20:54:10+00:00 https://biolegacyresearch.com/energy-and-commerce-committee-seeks-details-on-fdas-stem-cell-enforcement/ 2019-07-26T20:58:07+00:00 https://biolegacyresearch.com/cder-issues-guidance-on-next-generation-sequencing-data-for-antiviral-products/ 2019-08-13T18:48:02+00:00 https://biolegacyresearch.com/fda-posts-final-guidance-on-rems-modifications/ 2019-08-13T18:49:13+00:00 https://biolegacyresearch.com/fda-warns-three-drugmakers-for-gmp-slipups/ 2019-08-13T18:50:54+00:00 https://biolegacyresearch.com/483-roundup-fda-hits-six-drugmakers-for-gmp-violations/ 2019-08-13T18:52:29+00:00 https://biolegacyresearch.com/who-issues-revised-guidance-on-qms-requirements/ 2019-08-13T18:53:59+00:00 https://biolegacyresearch.com/fda-releases-recommendations-on-using-the-inactive-ingredient-database/ 2019-08-13T18:56:03+00:00 https://biolegacyresearch.com/u-s-urges-eu-to-delay-implementing-eu-mdr-ivdr-by-three-years/ 2019-08-15T19:24:41+00:00 https://biolegacyresearch.com/fda-finalizes-guidance-on-postmarketing-safety-reporting-for-combination-products/ 2019-08-15T19:26:35+00:00 https://biolegacyresearch.com/fda-warns-clinicon-for-lax-testing-validation-of-sterilization-processes/ 2019-08-15T19:28:16+00:00 https://biolegacyresearch.com/industry-supports-reclassification-of-surgical-staplers-but-adds-caution/ 2019-08-15T19:29:41+00:00 https://biolegacyresearch.com/fda-issues-draft-guidance-on-labeling-of-combination-products/ 2019-08-15T19:31:12+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-five-firms-for-complaints-validations/ 2019-08-15T19:34:43+00:00 https://biolegacyresearch.com/fda-warns-of-security-holes-in-medtronics-insulin-pumps/ 2019-08-15T19:37:29+00:00 https://biolegacyresearch.com/canada-issues-new-premarket-requirements-for-cybersecurity/ 2019-08-15T19:39:07+00:00 https://biolegacyresearch.com/france-issues-eus-first-cybersecurity-guidelines/ 2019-08-15T19:40:40+00:00 https://biolegacyresearch.com/washington-drugmaker-cited-for-lacking-quality-unit/ 2019-08-26T22:02:41+00:00 https://biolegacyresearch.com/florida-lays-out-plan-to-import-canadian-drugs/ 2019-08-27T22:13:44+00:00 https://biolegacyresearch.com/baxalta-loses-motion-for-patent-infringement-retrial-against-bayer/ 2019-08-27T22:14:29+00:00 https://biolegacyresearch.com/chinese-otc-firm-warned-for-falling-short-on-testing/ 2019-08-27T22:15:33+00:00 https://biolegacyresearch.com/fda-requests-recall-of-florida-compounders-sterile-products/ 2019-08-27T22:17:28+00:00 https://biolegacyresearch.com/fda-inspection-of-novartis-lab-raises-more-questions-about-data-falsification/ 2019-09-11T17:27:36+00:00 https://biolegacyresearch.com/grassley-calls-for-unannounced-inspections-of-foreign-drugmakers/ 2019-09-11T17:29:08+00:00 https://biolegacyresearch.com/warning-letter-roundup-facilities-scolded-for-multiple-slipups/ 2019-09-11T17:34:13+00:00 https://biolegacyresearch.com/483-roundup-seven-companies-cited-for-quality-transgressions/ 2019-09-11T17:35:47+00:00 https://biolegacyresearch.com/cder-plans-pilot-to-test-clinical-data-interchange-standard/ 2019-09-11T17:37:25+00:00 https://biolegacyresearch.com/fda-and-niimbl-team-up-on-advanced-manufacturing/ 2019-09-11T17:39:08+00:00 https://biolegacyresearch.com/industry-questions-eu-specifications-for-reprocessing-single-use-devices/ 2019-09-16T16:26:54+00:00 https://biolegacyresearch.com/imdrf-seeks-feedback-on-adverse-event-reporting-terms/ 2019-09-16T16:29:18+00:00 https://biolegacyresearch.com/fda-hits-houston-devicemaker-with-lengthy-warning-letter/ 2019-09-16T16:31:46+00:00 https://biolegacyresearch.com/russia-implements-new-quality-control-requirements/ 2019-09-16T16:33:07+00:00 https://biolegacyresearch.com/duodenoscopes-need-better-designs-to-avoid-reprocessing-fda-says/ 2019-09-16T16:34:44+00:00 https://biolegacyresearch.com/fda-issues-warning-to-indiana-devicemaker/ 2019-09-16T16:36:11+00:00 https://biolegacyresearch.com/483-roundup-fda-flags-six-firms-for-gmp-other-failures/ 2019-09-16T16:48:11+00:00 https://biolegacyresearch.com/china-launches-pilot-program-for-unique-device-identifier-system/ 2019-09-16T16:51:06+00:00 https://biolegacyresearch.com/federal-judge-dismisses-149-lawsuits-over-abilifys-side-effects/ 2019-09-25T22:52:00+00:00 https://biolegacyresearch.com/fda-warns-chinese-firm-for-testing-validation-failures/ 2019-09-25T22:54:23+00:00 https://biolegacyresearch.com/california-otc-firm-written-up-for-missing-validations-product-reviews/ 2019-09-25T22:55:18+00:00 https://biolegacyresearch.com/advisory-committees-turn-down-opana-ir-pediatric-labeling/ 2019-09-26T21:43:47+00:00 https://biolegacyresearch.com/cder-reorganization-gets-under-way/ 2019-09-26T21:44:28+00:00 https://biolegacyresearch.com/california-finds-drugmakers-increased-list-prices-way-above-inflation/ 2019-09-26T21:45:20+00:00 https://biolegacyresearch.com/fdas-top-ten-gmp-inspection-findings-for-fy-2019/ 2019-10-09T20:56:12+00:00 https://biolegacyresearch.com/online-pharmacy-urges-fda-to-pull-all-ranitidine-products/ 2019-10-09T20:57:37+00:00 https://biolegacyresearch.com/warning-letter-roundup-three-firms-slapped-for-quality-issues/ 2019-10-09T20:59:42+00:00 https://biolegacyresearch.com/avexis-issues-detailed-response-to-zolgensma-form-483/ 2019-10-09T21:01:34+00:00 https://biolegacyresearch.com/fda-offers-more-time-to-join-quality-metrics-feedback-program/ 2019-10-09T21:03:42+00:00 https://biolegacyresearch.com/fda-warns-galt-pharmaceuticals-for-misleading-email/ 2019-10-09T21:04:55+00:00 https://biolegacyresearch.com/483-roundup-five-companies-cited-for-various-problems/ 2019-10-09T21:07:10+00:00 https://biolegacyresearch.com/fdas-top-ten-gmp-citations-for-fy-2019/ 2019-10-14T18:35:08+00:00 https://biolegacyresearch.com/ec-releases-guidelines-on-benefit-risk-analysis-for-phthalates/ 2019-10-14T18:36:47+00:00 https://biolegacyresearch.com/fda-pilots-accreditation-scheme-for-conformity-assessment/ 2019-10-14T18:38:41+00:00 https://biolegacyresearch.com/fda-creates-new-safer-technologies-program/ 2019-10-14T18:41:42+00:00 https://biolegacyresearch.com/483-roundup-fda-hits-six-firms-for-quality-management-lapses/ 2019-10-14T18:43:23+00:00 https://biolegacyresearch.com/imdrf-flags-lack-of-global-alignment-in-cybersecurity/ 2019-10-14T18:45:04+00:00 https://biolegacyresearch.com/reckitt-settles-multistate-suboxone-claims-for-700-million/ 2019-10-24T21:32:42+00:00 https://biolegacyresearch.com/fda-clarifies-its-approach-to-postmarket-studies-and-clinical-trials/ 2019-10-24T21:33:26+00:00 https://biolegacyresearch.com/fda-changes-approach-to-homeopathic-products-sharpless-says/ 2019-10-24T21:34:58+00:00 https://biolegacyresearch.com/fda-task-force-supports-rating-system-for-drug-shortages-woodcock-says/ 2019-10-25T22:54:09+00:00 https://biolegacyresearch.com/fda-suggests-alternative-ndma-test-for-ranitidine/ 2019-10-25T22:54:52+00:00 https://biolegacyresearch.com/glaxosmithkline-loses-bid-to-end-zofran-lawsuits/ 2019-10-25T22:56:43+00:00 https://biolegacyresearch.com/iowa-drugmaker-cited-for-quality-violations/ 2019-10-25T22:57:32+00:00 https://biolegacyresearch.com/fda-investigates-implantable-devices-that-contain-metals/ 2019-11-12T20:20:18+00:00 https://biolegacyresearch.com/fda-calls-for-boxed-warning-on-breast-implants/ 2019-11-12T20:22:50+00:00 https://biolegacyresearch.com/fda-issues-labeling-advice-for-intravascular-devices/ 2019-11-12T20:24:42+00:00 https://biolegacyresearch.com/fda-warns-wheelchair-manufacturer-for-misbranding/ 2019-11-12T20:26:08+00:00 https://biolegacyresearch.com/hhs-inspector-general-to-analyze-postmarket-surveillance/ 2019-11-12T20:27:42+00:00 https://biolegacyresearch.com/483-roundup-six-firms-cited-for-quality-other-compliance-failures/ 2019-11-12T20:30:43+00:00 https://biolegacyresearch.com/cdrh-releases-guidance-priorities-for-fiscal-2020/ 2019-11-12T20:32:07+00:00 https://biolegacyresearch.com/fda-plans-to-exempt-five-class-ii-devices-from-premarket-notification/ 2019-11-12T20:33:54+00:00 https://biolegacyresearch.com/drug-shortage-task-force-finds-a-broken-marketplace-say-sharpless-woodcock/ 2019-11-14T19:34:49+00:00 https://biolegacyresearch.com/fda-seeks-feedback-on-best-practices-for-postmarket-surveillance/ 2019-11-14T19:36:43+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-warns-six-facilities-for-gmp-other-failures/ 2019-11-14T19:38:56+00:00 https://biolegacyresearch.com/483-roundup-fda-hits-seven-firms-for-gmp-quality-violations/ 2019-11-14T19:40:56+00:00 https://biolegacyresearch.com/woodcock-to-congress-u-s-must-revamp-manufacturing-to-spur-apis/ 2019-11-14T19:41:00+00:00 https://biolegacyresearch.com/fda-cites-two-aurobindo-facilities-for-serious-gmp-violations/ 2019-11-23T20:26:54+00:00 https://biolegacyresearch.com/continuing-resolution-keeps-fda-funded-through-dec-20/ 2019-11-25T22:44:00+00:00 https://biolegacyresearch.com/fda-seeks-to-speed-insulin-biosimilar-approvals-with-new-guidance/ 2019-11-25T22:51:50+00:00 https://biolegacyresearch.com/florida-stem-cell-supplier-draws-untitled-letter-for-false-claims/ 2019-11-25T22:53:37+00:00 https://biolegacyresearch.com/novartis-boosts-heart-treatment-portfolio-with-9-7-billion-deal/ 2019-11-25T23:35:48+00:00 https://biolegacyresearch.com/who-issues-guidance-on-complying-with-data-integrity-regulations/ 2019-12-17T22:39:08+00:00 https://biolegacyresearch.com/pic-s-drafts-recommendations-on-risk-based-change-management-for-quality-systems/ 2019-12-17T22:40:00+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-warns-six-firms-for-gmp-other-violations/ 2019-12-17T22:40:49+00:00 https://biolegacyresearch.com/fda-issues-guidance-on-transdermal-and-topical-drug-delivery-systems/ 2019-12-17T22:41:32+00:00 https://biolegacyresearch.com/483-roundup-five-asian-companies-cited-for-quality-deficiencies/ 2019-12-17T22:42:26+00:00 https://biolegacyresearch.com/czech-firm-gets-non-compliance-letter-for-serious-deficiencies/ 2019-12-17T22:43:30+00:00 https://biolegacyresearch.com/fda-clarifies-guidance-on-export-certificate-denials/ 2019-12-17T23:03:29+00:00 https://biolegacyresearch.com/ema-group-flags-concerns-over-notified-bodies-assessing-companion-diagnostics/ 2019-12-17T23:04:17+00:00 https://biolegacyresearch.com/fda-warns-device-manufacturer-sterilizer-in-texas/ 2019-12-17T23:12:49+00:00 https://biolegacyresearch.com/fda-explains-new-510k-pathway-for-magnetic-resonance-coils/ 2019-12-17T23:13:44+00:00 https://biolegacyresearch.com/industry-urges-australia-to-follow-international-samd-classifications/ 2019-12-17T23:14:31+00:00 https://biolegacyresearch.com/lawmakers-say-implant-claims-should-include-udis/ 2019-12-17T23:15:35+00:00 https://biolegacyresearch.com/483-roundup-fda-flags-six-devicemakers-for-gmp-lapses/ 2019-12-17T23:16:33+00:00 https://biolegacyresearch.com/health-canada-announces-new-medical-device-directorate/ 2019-12-17T23:17:24+00:00 https://biolegacyresearch.com/australian-court-finds-jj-liable-for-mesh-injuries/ 2019-12-17T23:18:17+00:00 https://biolegacyresearch.com/teva-called-out-for-complaint-handling-written-procedures/ 2019-12-20T22:38:36+00:00 https://biolegacyresearch.com/2019-in-review-a-flurry-of-major-drug-mergers-and-acquisitions/ 2019-12-25T22:15:00+00:00 https://biolegacyresearch.com/top-warning-letter-trends-of-2019/ 2019-12-25T22:16:00+00:00 https://biolegacyresearch.com/california-drugmaker-rapped-for-data-backups-other-violations/ 2019-12-25T22:18:00+00:00 https://biolegacyresearch.com/canadian-ambassador-distributors-reject-u-s-import-plan/ 2019-12-25T22:43:00+00:00 https://biolegacyresearch.com/ranitidine-can-generate-ndma-under-storage-conditions-lab-says/ 2020-01-13T22:37:25+00:00 https://biolegacyresearch.com/warning-letter-roundup-u-s-firms-hit-for-gmps-other-letdowns/ 2020-01-13T22:39:18+00:00 https://biolegacyresearch.com/regulators-target-diabetes-drug-metformin-for-ndma-contamination/ 2020-01-13T22:40:38+00:00 https://biolegacyresearch.com/483-roundup-seven-firms-rapped-for-complaint-handling-other-issues/ 2020-01-13T22:42:54+00:00 https://biolegacyresearch.com/swiss-regulator-writes-up-indian-firm-for-multiple-violations/ 2020-01-13T22:44:07+00:00 https://biolegacyresearch.com/federal-judge-says-fda-cant-regulate-barium-product-as-a-drug/ 2020-01-13T22:45:26+00:00 https://biolegacyresearch.com/canada-releases-final-guidance-on-software-as-a-medical-device/ 2020-01-14T19:51:00+00:00 https://biolegacyresearch.com/new-iso-standard-helps-devicemakers-manage-risk/ 2020-01-14T19:55:21+00:00 https://biolegacyresearch.com/eu-rolls-out-new-guidance-on-cybersecurity/ 2020-01-14T20:20:56+00:00 https://biolegacyresearch.com/chinese-devicemaker-warned-for-testing-deficiencies/ 2020-01-14T20:24:43+00:00 https://biolegacyresearch.com/fda-issues-guidance-on-pta-balloon-specialty-catheter-510k-submissions/ 2020-01-14T20:48:13+00:00 https://biolegacyresearch.com/483-roundup-fda-hits-six-firms-for-quality-lapses/ 2020-01-14T20:52:34+00:00 https://biolegacyresearch.com/bts-research-passes-an-fda-bioresearch-monitoring-program-inspection-for-glp-rat-and-dog-toxicity-studies/ 2020-01-23T00:08:34+00:00 https://biolegacyresearch.com/wp-content/uploads/2018/12/pdf.png https://biolegacyresearch.com/fda-details-new-user-fee-structure-for-biosimilars/ 2020-01-23T23:11:19+00:00 https://biolegacyresearch.com/fda-shares-its-thinking-on-drug-drug-interaction-studies/ 2020-01-23T23:12:15+00:00 https://biolegacyresearch.com/cder-outlines-cgmps-and-exemptions-for-outsourcing-facilities/ 2020-01-23T23:13:53+00:00 https://biolegacyresearch.com/ema-clarifies-gmp-responsibilities-for-marketing-authorization-holders/ 2020-01-23T23:14:40+00:00 https://biolegacyresearch.com/icer-issues-cost-benefit-analysis-on-three-sickle-cell-disease-treatments/ 2020-01-24T22:59:10+00:00 https://biolegacyresearch.com/gilead-files-counterclaim-against-hhs-in-truvada-patent-case/ 2020-01-24T22:59:51+00:00 https://biolegacyresearch.com/blood-cancer-trials-may-use-minimal-residual-disease-measures-as-endpoints-guidance-says/ 2020-01-24T23:00:33+00:00 https://biolegacyresearch.com/otc-maker-gets-warning-letter-for-gmp-violations-unapproved-drug/ 2020-01-24T23:01:15+00:00 https://biolegacyresearch.com/who-launches-global-program-for-inspections-of-sterile-drugmakers/ 2020-02-03T22:16:28+00:00 https://biolegacyresearch.com/fda-official-action-indicated-classifications-drop-sharply/ 2020-02-03T22:19:19+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-warns-six-firms-for-gmp-lapses/ 2020-02-03T22:22:22+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-facilities-in-the-u-s-china-and-india/ 2020-02-03T22:23:35+00:00 https://biolegacyresearch.com/fda-issues-update-on-pilot-accreditation-scheme-for-conformity-assessments/ 2020-02-07T23:39:35+00:00 https://biolegacyresearch.com/uk-offers-grace-period-for-sudden-notified-body-withdrawals/ 2020-02-07T23:40:49+00:00 https://biolegacyresearch.com/fda-warns-massachusetts-firm-over-uncleared-device-modifications/ 2020-02-07T23:42:02+00:00 https://biolegacyresearch.com/medtech-europe-renews-alarm-over-mdr-transition/ 2020-02-07T23:43:27+00:00 https://biolegacyresearch.com/proposed-bill-would-allow-fda-to-destroy-counterfeit-products/ 2020-02-07T23:44:38+00:00 https://biolegacyresearch.com/483-roundup-six-facilities-cited-for-quality-lapses/ 2020-02-07T23:46:55+00:00 https://biolegacyresearch.com/taiwan-includes-quality-requirements-in-new-medical-device-law/ 2020-02-07T23:48:08+00:00 https://biolegacyresearch.com/fda-schedules-workshop-on-virtual-and-augmented-reality-in-medicine/ 2020-02-07T23:49:00+00:00 https://biolegacyresearch.com/fda-publishes-details-on-gene-drug-interactions/ 2020-02-20T23:13:13+00:00 https://biolegacyresearch.com/foreign-governments-free-riding-on-u-s-drug-research-white-house-says/ 2020-02-20T23:14:14+00:00 https://biolegacyresearch.com/fda-revises-guidance-on-electronic-drug-submissions/ 2020-02-21T22:53:43+00:00 https://biolegacyresearch.com/gilead-loses-ptab-patent-challenges/ 2020-02-21T22:54:38+00:00 https://biolegacyresearch.com/indian-drugmaker-cited-in-eu-for-serious-gmp-violations/ 2020-02-21T22:55:27+00:00 https://biolegacyresearch.com/three-more-states-pursue-drug-price-controls/ 2020-02-21T23:21:42+00:00 https://biolegacyresearch.com/fda-grants-priority-review-for-liso-cel-in-b-cell-lymphoma/ 2020-02-24T18:26:55+00:00 https://biolegacyresearch.com/soligenix-nabs-fast-track-status-for-rivax/ 2020-02-24T18:27:58+00:00 https://biolegacyresearch.com/fda-approves-three-drugs-through-rx-to-otc-switch-process/ 2020-02-24T18:28:55+00:00 https://biolegacyresearch.com/eisai-withdraws-belviq-over-cancer-concerns/ 2020-02-24T18:30:03+00:00 https://biolegacyresearch.com/cber-issues-2020-guidance-agenda/ 2020-02-24T18:31:41+00:00 https://biolegacyresearch.com/first-genetic-test-for-fragile-x-syndrome-cleared/ 2020-02-24T19:29:56+00:00 https://biolegacyresearch.com/cdc-issues-new-coronavirus-test-reagents/ 2020-02-24T19:31:16+00:00 https://biolegacyresearch.com/fist-assist-devices-earns-ce-mark-for-vein-compression-device/ 2020-02-24T19:32:33+00:00 https://biolegacyresearch.com/irelands-nsai-becomes-11th-notified-body-under-eu-mdr/ 2020-02-24T19:33:34+00:00 https://biolegacyresearch.com/coronavirus-outbreak-former-fda-commissioner-api-manufacturers-call-for-action/ 2020-03-03T23:38:10+00:00 https://biolegacyresearch.com/pharma-companies-support-use-of-blockchain-for-drug-tracking/ 2020-03-03T23:39:46+00:00 https://biolegacyresearch.com/warning-letters-fda-warns-drugmakers-in-china-and-germany/ 2020-03-03T23:41:45+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-seven-firms-for-gmp-quality-lapses/ 2020-03-03T23:45:45+00:00 https://biolegacyresearch.com/who-considers-unit-level-serial-numbers-for-drug-tracking/ 2020-03-03T23:47:06+00:00 https://biolegacyresearch.com/fda-allows-early-release-of-covid-19-diagnostics/ 2020-03-06T21:14:08+00:00 https://biolegacyresearch.com/no-reported-device-shortages-from-coronavirus-outbreak-fda-says/ 2020-03-06T21:17:17+00:00 https://biolegacyresearch.com/rhode-island-firm-draws-warning-for-design-controls/ 2020-03-06T21:18:51+00:00 https://biolegacyresearch.com/mask-maker-warned-for-unapproved-device/ 2020-03-06T21:20:45+00:00 https://biolegacyresearch.com/korean-facility-warned-for-repeat-violations/ 2020-03-06T21:24:36+00:00 https://biolegacyresearch.com/483-roundup-six-devicemakers-cited-for-gmp-violations/ 2020-03-06T21:28:11+00:00 https://biolegacyresearch.com/fda-revises-guidance-on-510ks-for-atherectomy-devices/ 2020-03-06T21:29:46+00:00 https://biolegacyresearch.com/uk-introduces-new-legislation-to-overhaul-medical-device-authority/ 2020-03-06T21:30:58+00:00 https://biolegacyresearch.com/nsai-named-11th-notified-body-under-eu-mdr/ 2020-03-06T21:32:15+00:00 https://biolegacyresearch.com/fda-eases-rems-requirements-during-coronavirus-outbreak/ 2020-03-23T22:56:27+00:00 https://biolegacyresearch.com/fda-warns-of-possible-failure-of-epipen-injectors/ 2020-03-24T20:59:00+00:00 https://biolegacyresearch.com/cdrh-extends-response-dates-for-marketing-applications/ 2020-03-24T21:07:47+00:00 https://biolegacyresearch.com/denmark-expands-adverse-event-reporting-requirements/ 2020-03-24T21:09:01+00:00 https://biolegacyresearch.com/gileads-remdesivir-gains-orphan-drug-status-as-possible-covid-19-treatment/ 2020-03-24T22:38:51+00:00 https://biolegacyresearch.com/fda-lifts-ban-on-indian-firm-to-facilitate-hydroxychloroquine-chloroquine-shipments/ 2020-03-24T22:40:01+00:00 https://biolegacyresearch.com/fda-warns-danish-drugmaker-for-testing-failures/ 2020-03-24T22:41:31+00:00 https://biolegacyresearch.com/california-manufacturer-rapped-for-particulate-contamination/ 2020-03-24T22:43:36+00:00 https://biolegacyresearch.com/fda-suspends-routine-inspections/ 2020-04-08T18:18:00+00:00 https://biolegacyresearch.com/fda-strengthens-supply-chain-reporting-during-pandemic/ 2020-04-08T18:21:00+00:00 https://biolegacyresearch.com/fda-offers-advice-on-adverse-event-reporting-during-a-pandemic/ 2020-04-08T18:30:00+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-warns-six-foreign-drugmakers/ 2020-04-08T18:34:00+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-five-firms-for-quality-failures/ 2020-04-08T18:38:00+00:00 https://biolegacyresearch.com/trump-invokes-wartime-legislation-to-fight-coronavirus-outbreak/ 2020-04-08T18:40:00+00:00 https://biolegacyresearch.com/colorado-submits-its-drug-importation-plan-for-approval/ 2020-04-08T18:43:00+00:00 https://biolegacyresearch.com/hhs-gives-liability-cover-for-coronavirus-countermeasures/ 2020-04-15T21:11:58+00:00 https://biolegacyresearch.com/fda-eases-adverse-event-reporting-requirements-during-the-pandemic/ 2020-04-15T21:16:04+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-warns-four-devicemakers/ 2020-04-15T21:18:00+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-six-firms-for-quality-failures/ 2020-04-15T21:21:54+00:00 https://biolegacyresearch.com/neurometrix-ordered-to-pay-4-million-for-deceptive-advertising/ 2020-04-15T21:23:27+00:00 https://biolegacyresearch.com/fda-bans-electrical-stimulation-devices-for-aggression-and-self-harm/ 2020-04-15T21:25:13+00:00 https://biolegacyresearch.com/astrazeneca-tests-diabetes-drug-as-covid-19-treatment-in-phase-3-trial/ 2020-04-24T04:01:00+00:00 https://biolegacyresearch.com/fda-approves-immunomedics-breast-cancer-treatment-trodelvy/ 2020-04-24T04:02:00+00:00 https://biolegacyresearch.com/fda-approves-sanofis-meningococcal-vaccine/ 2020-04-24T04:02:00+00:00 https://biolegacyresearch.com/valneva-and-dynavax-collaborate-to-develop-covid-19-vaccine/ 2020-04-24T04:02:00+00:00 https://biolegacyresearch.com/insmeds-brensocatib-enters-trial-as-possible-covid-19-treatment/ 2020-04-24T04:02:00+00:00 https://biolegacyresearch.com/new-york-files-opioid-fraud-charges-against-mallinckrodt/ 2020-04-24T04:02:00+00:00 https://biolegacyresearch.com/jj-partners-with-emergent-to-produce-covid-19-vaccine/ 2020-04-24T04:03:00+00:00 https://biolegacyresearch.com/fda-eases-requirements-for-repackaging-of-propofol/ 2020-04-24T04:03:00+00:00 https://biolegacyresearch.com/remdesivir-trial-data-leak-shows-no-benefits-in-covid-19-patients/ 2020-04-24T04:03:00+00:00 https://biolegacyresearch.com/mhra-temporarily-eases-some-gmp-requirements/ 2020-04-24T04:03:00+00:00 https://biolegacyresearch.com/covid-19-response/ 2020-04-30T21:38:25+00:00 https://biolegacyresearch.com/wp-content/uploads/2020/04/image001.jpg https://biolegacyresearch.com/ema-recommends-extending-gmp-certificates-until-end-of-2021/ 2020-05-05T19:06:34+00:00 https://biolegacyresearch.com/ema-creates-new-drug-shortage-reporting-system/ 2020-05-05T19:10:39+00:00 https://biolegacyresearch.com/fda-hits-pfizer-facility-in-india-for-shoddy-sterility-testing/ 2020-05-05T19:15:32+00:00 https://biolegacyresearch.com/oregon-compounder-hit-for-poor-aseptic-practices/ 2020-05-05T19:19:26+00:00 https://biolegacyresearch.com/online-pharmacy-warned-for-selling-unapproved-covid-19-products/ 2020-05-05T19:20:33+00:00 https://biolegacyresearch.com/cder-issues-staff-manual-on-the-newly-identified-safety-signal-process/ 2020-05-05T19:21:30+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-eight-firms-for-quality-issues/ 2020-05-05T19:22:56+00:00 https://biolegacyresearch.com/fda-eases-supply-chain-requirements-during-pandemic/ 2020-05-05T19:24:59+00:00 https://biolegacyresearch.com/imdrf-calls-for-harmonized-approach-for-adverse-event-reports-cybersecurity/ 2020-05-12T23:05:01+00:00 https://biolegacyresearch.com/european-commission-delays-mdr-for-another-year-due-to-covid-19/ 2020-05-12T23:05:33+00:00 https://biolegacyresearch.com/hungarian-devicemaker-warned-for-poor-design-process-controls/ 2020-05-12T23:05:55+00:00 https://biolegacyresearch.com/thai-condom-manufacturer-draws-warning-for-gmp-failures/ 2020-05-12T23:06:18+00:00 https://biolegacyresearch.com/fda-warns-chinese-devicemaker-for-quality-failures/ 2020-05-12T23:06:43+00:00 https://biolegacyresearch.com/fda-loosens-regulations-on-digital-pathology-devices-during-outbreak/ 2020-05-12T23:07:05+00:00 https://biolegacyresearch.com/483-roundup-six-devicemakers-rapped-for-quality-lapses/ 2020-05-12T23:07:35+00:00 https://biolegacyresearch.com/tga-fines-oxymed-australia-for-covid-19-advertising-claims/ 2020-05-12T23:07:58+00:00 https://biolegacyresearch.com/fda-wants-proof-of-reliability-for-emergency-use-injectors/ 2020-05-12T23:08:23+00:00 https://biolegacyresearch.com/europes-mdcg-releases-guidance-on-class-1-transitions-under-mdr/ 2020-05-12T23:08:53+00:00 https://biolegacyresearch.com/new-jersey-contract-tester-warned-for-api-testing-violations/ 2020-05-21T04:02:00+00:00 https://biolegacyresearch.com/biomerieuxs-covid-19-antibody-tests-obtain-ce-mark/ 2020-05-22T04:02:00+00:00 https://biolegacyresearch.com/baxter-earns-ce-mark-for-syringe-infusion-system/ 2020-05-22T04:02:00+00:00 https://biolegacyresearch.com/fujifilm-begins-research-on-ai-tech-for-covid-19-pneumonia/ 2020-05-22T04:02:00+00:00 https://biolegacyresearch.com/large-hydroxychloroquine-study-gets-under-way/ 2020-05-22T04:03:00+00:00 https://biolegacyresearch.com/trinetx-harvard-pilgrim-health-care-institute-to-monitor-covid-19-drug-usage/ 2020-05-22T04:03:00+00:00 https://biolegacyresearch.com/astrazeneca-receives-1-2-billion-barda-contract-for-covid-19-vaccine/ 2020-05-22T04:03:00+00:00 https://biolegacyresearch.com/fda-adds-morphine-epinephrine-to-covid-19-compounding-list/ 2020-05-22T04:03:00+00:00 https://biolegacyresearch.com/fda-issues-dozens-of-warnings-for-sham-covid-19-products/ 2020-06-02T20:04:16+00:00 https://biolegacyresearch.com/woodcock-temporarily-steps-down-as-cder-director/ 2020-06-02T20:06:29+00:00 https://biolegacyresearch.com/fda-collaborating-with-cdc-to-restart-routine-on-site-inspections/ 2020-06-02T20:08:07+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-warns-four-firms-for-quality-failures/ 2020-06-02T20:51:32+00:00 https://biolegacyresearch.com/pennsylvania-api-maker-rapped-for-supplier-verifications/ 2020-06-02T21:06:37+00:00 https://biolegacyresearch.com/time-cap-laboratories-cited-for-gmp-lapses/ 2020-06-02T21:36:40+00:00 https://biolegacyresearch.com/swissmedic-cites-indian-api-maker-for-quality-lapses/ 2020-06-02T21:52:27+00:00 https://biolegacyresearch.com/pharma-balks-at-congressional-plans-for-domestic-drug-manufacturing/ 2020-06-02T21:54:15+00:00 https://biolegacyresearch.com/korean-firm-cited-for-environmental-monitoring-lab-controls/ 2020-06-02T21:55:58+00:00 https://biolegacyresearch.com/academics-pharmacists-call-for-drug-quality-rating-system/ 2020-06-02T21:57:24+00:00 https://biolegacyresearch.com/device-consortium-requests-feedback-on-real-world-evidence-framework-for-ivds/ 2020-06-04T20:32:29+00:00 https://biolegacyresearch.com/european-ce-certificates-up-50-percent/ 2020-06-04T20:34:06+00:00 https://biolegacyresearch.com/failure-to-validate-software-draws-warning-for-uks-bedfont-scientific/ 2020-06-04T20:37:28+00:00 https://biolegacyresearch.com/philosys-fails-to-submit-mdrs-for-glucose-meter-failures/ 2020-06-04T20:38:52+00:00 https://biolegacyresearch.com/perahealth-lacks-design-plans-for-software/ 2020-06-04T20:42:43+00:00 https://biolegacyresearch.com/mexicos-dj-orthopedics-cited-for-lax-capa-procedures/ 2020-06-04T20:46:40+00:00 https://biolegacyresearch.com/deerfield-imaging-fails-to-document-capas-for-x-ray/ 2020-06-04T20:47:59+00:00 https://biolegacyresearch.com/european-commission-issues-guidance-on-safety-reporting/ 2020-06-04T20:55:50+00:00 https://biolegacyresearch.com/fda-issues-template-for-at-home-covid-19-tests/ 2020-06-04T20:57:09+00:00 https://biolegacyresearch.com/fda-outlines-gmps-for-drugmakers-dealing-with-covid-19-infections-in-workers/ 2020-06-22T04:02:00+00:00 https://biolegacyresearch.com/european-pharma-groups-calls-for-cooperation-between-eu-and-uk-regulators/ 2020-06-23T04:01:00+00:00 https://biolegacyresearch.com/keytruda-approved-in-china-for-esophageal-squamous-cell-carcinoma/ 2020-06-23T04:02:00+00:00 https://biolegacyresearch.com/akili-grabs-ce-mark-for-childrens-digital-adhd-treatment/ 2020-06-23T04:02:00+00:00 https://biolegacyresearch.com/glenmark-pharmaceuticals-gets-indian-approval-for-favipiravir-as-a-covid-19-treatment/ 2020-06-23T04:02:00+00:00 https://biolegacyresearch.com/mainstay-medicals-chronic-low-back-pain-device-approved/ 2020-06-23T04:02:00+00:00 https://biolegacyresearch.com/preceptis-ear-tube-system-receives-fda-clearance/ 2020-06-23T04:02:00+00:00 https://biolegacyresearch.com/fda-warns-canadian-sterile-drugmaker-for-aseptic-practices/ 2020-06-23T04:02:00+00:00 https://biolegacyresearch.com/gilead-sciences-gears-up-for-clinical-trials-of-inhaled-remdesivir/ 2020-06-23T04:03:00+00:00 https://biolegacyresearch.com/nih-and-novartis-end-late-stage-hydroxychloroquine-trials/ 2020-06-23T04:03:00+00:00 https://biolegacyresearch.com/ridgeback-biotherapeutics-to-launch-two-trials-of-its-covid-19-antiviral/ 2020-06-23T04:03:00+00:00 https://biolegacyresearch.com/fda-releases-new-program-for-combination-product-inspections/ 2020-07-06T21:44:44+00:00 https://biolegacyresearch.com/takeda-warned-for-unresolved-issues-with-natpara/ 2020-07-06T21:45:43+00:00 https://biolegacyresearch.com/canadian-drugmaker-draws-fda-warning-letter/ 2020-07-06T21:46:46+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-five-firms-for-quality-violations/ 2020-07-06T21:48:45+00:00 https://biolegacyresearch.com/california-compounder-draws-warning-for-repeated-violations/ 2020-07-06T21:49:41+00:00 https://biolegacyresearch.com/nabriva-hit-with-a-second-complete-response-letter-for-antibiotic/ 2020-07-06T21:50:58+00:00 https://biolegacyresearch.com/usp-supports-use-of-crab-derived-reagents-for-drug-tests/ 2020-07-06T21:52:06+00:00 https://biolegacyresearch.com/fda-outlines-gmps-for-covid-19-infections-in-workers/ 2020-07-06T21:53:17+00:00 https://biolegacyresearch.com/public-citizen-pushes-for-boxed-warning-on-type-2-diabetes-drugs/ 2020-07-06T21:56:32+00:00 https://biolegacyresearch.com/fda-delays-certain-udi-requirements-during-pandemic/ 2020-07-07T21:45:29+00:00 https://biolegacyresearch.com/former-fdaer-says-allowing-developers-to-self-validate-covid-19-tests-led-to-chaos/ 2020-07-07T21:46:46+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-warns-six-firms-for-serious-violations/ 2020-07-07T21:48:09+00:00 https://biolegacyresearch.com/483-roundup-three-firms-cited-for-quality-failures/ 2020-07-07T21:49:30+00:00 https://biolegacyresearch.com/australias-tga-re-tests-covid-19-antibody-tests/ 2020-07-07T21:53:40+00:00 https://biolegacyresearch.com/fort-worth-otc-maker-written-up-for-lack-of-testing/ 2020-07-22T04:02:00+00:00 https://biolegacyresearch.com/norlase-gets-ce-mark-for-leaf-laser/ 2020-07-23T04:02:00+00:00 https://biolegacyresearch.com/genfit-ends-phase-3-trial-of-nash-drug-elanfibranor-after-finding-no-benefit/ 2020-07-23T04:02:00+00:00 https://biolegacyresearch.com/lawmakers-call-for-answers-on-covid-19-antibody-test-scams/ 2020-07-23T04:02:00+00:00 https://biolegacyresearch.com/jazz-pharmaceuticals-xywav-approved-for-narcolepsy/ 2020-07-23T04:02:00+00:00 https://biolegacyresearch.com/glenmarks-fabiflu-shows-promise-for-covid-19-patients/ 2020-07-23T04:02:00+00:00 https://biolegacyresearch.com/dynavax-teams-up-with-medigen-on-covid-19-vaccine/ 2020-07-23T04:02:00+00:00 https://biolegacyresearch.com/gilead-takes-300-million-stake-in-cancer-antibody-developer-tizona/ 2020-07-23T04:02:00+00:00 https://biolegacyresearch.com/apotex-subsidiary-signa-gets-fda-warning-letter/ 2020-07-23T04:02:00+00:00 https://biolegacyresearch.com/u-s-to-pay-nearly-2-billion-for-pfizer-biontech-covid-19-vaccine/ 2020-07-23T04:03:00+00:00 https://biolegacyresearch.com/glenmarks-favipiravir-shows-promise-for-covid-19-patients/ 2020-07-23T04:03:00+00:00 https://biolegacyresearch.com/fda-to-resume-domestic-inspections-using-new-risk-assessment-system-hahn-says/ 2020-08-04T20:48:42+00:00 https://biolegacyresearch.com/uk-drugmakers-get-regulatory-relief-during-pandemic/ 2020-08-04T20:51:48+00:00 https://biolegacyresearch.com/fda-expands-guidance-on-pregnancy-and-lactation-labeling/ 2020-08-04T20:54:15+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-raps-four-drugmakers-for-quality-lapses/ 2020-08-04T20:56:16+00:00 https://biolegacyresearch.com/483-roundup-five-firms-cited-for-quality-failures/ 2020-08-04T20:58:19+00:00 https://biolegacyresearch.com/fda-releases-spring-regulatory-agenda/ 2020-08-04T21:00:01+00:00 https://biolegacyresearch.com/fda-extends-enforcement-discretion-deadline-for-regenerative-medicines/ 2020-08-04T21:01:25+00:00 https://biolegacyresearch.com/ema-posts-five-year-drug-regulatory-strategy-for-comment/ 2020-08-04T21:03:28+00:00 https://biolegacyresearch.com/medtech-europe-pushes-for-virtual-audits-under-mdr-ivdr/ 2020-08-06T21:02:06+00:00 https://biolegacyresearch.com/fda-resumes-domestic-inspections-using-new-risk-assessment-system/ 2020-08-06T21:03:34+00:00 https://biolegacyresearch.com/tga-reports-harm-caused-by-medical-software/ 2020-08-06T21:05:53+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-warns-devicemakers-for-unapproved-tests/ 2020-08-06T21:08:08+00:00 https://biolegacyresearch.com/483-roundup-four-firms-hit-for-quality-lapses/ 2020-08-06T21:10:13+00:00 https://biolegacyresearch.com/mhra-warns-of-phony-compliance-certificates/ 2020-08-06T21:11:37+00:00 https://biolegacyresearch.com/calls-for-urgent-reforms-at-mhra-due-to-safety-failings/ 2020-08-06T21:13:08+00:00 https://biolegacyresearch.com/fda-loosens-requirements-for-reserve-testing-samples/ 2020-08-20T04:02:00+00:00 https://biolegacyresearch.com/doj-alleges-teva-illegally-used-charities-for-copaxone-kickbacks/ 2020-08-20T04:02:00+00:00 https://biolegacyresearch.com/mercks-keytruda-improves-survival-for-esophageal-cancer-patients/ 2020-08-21T04:01:00+00:00 https://biolegacyresearch.com/pfizer-biontech-covid-19-vaccine-moves-into-pivotal-trial/ 2020-08-21T04:01:00+00:00 https://biolegacyresearch.com/siemens-healthineers-mri-software-cleared/ 2020-08-21T04:03:00+00:00 https://biolegacyresearch.com/jj-to-start-largest-phase-3-vaccine-trial-yet-in-september/ 2020-08-21T04:03:00+00:00 https://biolegacyresearch.com/sinopharm-to-begin-phase-3-trial-of-its-covid-19-vaccine-candidate-in-peru/ 2020-08-21T04:03:00+00:00 https://biolegacyresearch.com/lumiradx-rapid-covid-19-test-authorized-for-emergency-use/ 2020-08-21T04:03:00+00:00 https://biolegacyresearch.com/eu-curevac-near-advanced-purchase-agreement-for-covid-19-vaccine/ 2020-08-21T04:03:00+00:00 https://biolegacyresearch.com/smiths-medical-pulls-infusion-pumps-citing-software-error/ 2020-08-21T04:03:00+00:00 https://biolegacyresearch.com/trump-criticizes-fda-delay-of-convalescent-plasma-eua/ 2020-08-21T04:03:00+00:00 https://biolegacyresearch.com/opgen-earns-ce-mark-for-covid-19-diagnostic/ 2020-08-21T04:03:00+00:00 https://biolegacyresearch.com/mylans-generic-version-of-biogens-ms-drug-gets-fda-approval/ 2020-08-21T04:03:00+00:00 https://biolegacyresearch.com/proposed-senate-bill-would-give-fda-drug-recall-authority/ 2020-09-10T20:33:59+00:00 https://biolegacyresearch.com/las-vegas-compounder-warned-for-poor-aseptic-practices/ 2020-09-10T20:35:45+00:00 https://biolegacyresearch.com/mylan-api-plant-draws-fda-warning-letter/ 2020-09-10T20:37:15+00:00 https://biolegacyresearch.com/fda-warns-bangalore-drugmaker-for-contamination-investigations/ 2020-09-10T20:38:48+00:00 https://biolegacyresearch.com/ema-suspends-generics-tested-at-mumbai-lab/ 2020-09-10T20:40:15+00:00 https://biolegacyresearch.com/most-postmark-commitments-on-schedule-in-2019-fda-says/ 2020-09-10T20:46:49+00:00 https://biolegacyresearch.com/ema-calls-for-risk-evaluation-for-nitrosamines-in-some-biologics/ 2020-09-10T20:50:00+00:00 https://biolegacyresearch.com/doj-probes-sanofi-gsk-for-failure-to-disclose-contaminated-zantac/ 2020-09-10T20:51:59+00:00 https://biolegacyresearch.com/eu-sets-common-specifications-for-reprocessing-single-use-devices/ 2020-09-11T20:22:53+00:00 https://biolegacyresearch.com/tips-for-upgrading-your-medical-device-recall-strategy/ 2020-09-11T20:24:23+00:00 https://biolegacyresearch.com/fda-grants-eua-for-abbotts-card-based-covid-19-antigen-test/ 2020-09-11T20:26:00+00:00 https://biolegacyresearch.com/duodenoscope-maker-olympus-fails-to-submit-mdrs/ 2020-09-11T20:27:58+00:00 https://biolegacyresearch.com/hudson-scientific-falls-short-on-process-controls/ 2020-09-11T20:29:33+00:00 https://biolegacyresearch.com/menstrual-cup-maker-fails-on-validations/ 2020-09-11T20:33:17+00:00 https://biolegacyresearch.com/fda-revises-its-policy-on-multi-analyte-covid-19-euas/ 2020-09-11T20:35:39+00:00 https://biolegacyresearch.com/fda-releases-update-on-new-adverse-events-for-breast-implants/ 2020-09-11T20:37:11+00:00 https://biolegacyresearch.com/industry-supports-tga-move-to-exempt-some-software/ 2020-09-11T20:45:29+00:00 https://biolegacyresearch.com/hazard-analysis-key-in-risk-management-for-combo-products/ 2020-09-11T20:46:00+00:00 https://biolegacyresearch.com/administration-to-finalize-rule-to-allow-drug-imports-from-canada/ 2020-09-21T04:01:00+00:00 https://biolegacyresearch.com/diasorins-covid-19-test-gets-european-ok-for-saliva-samples/ 2020-09-21T04:02:00+00:00 https://biolegacyresearch.com/abbotts-over-the-counter-sport-glucose-sensor-gains-ce-mark/ 2020-09-21T04:02:00+00:00 https://biolegacyresearch.com/hhs-says-memo-wont-take-power-from-the-fda/ 2020-09-21T04:03:00+00:00 https://biolegacyresearch.com/state-treasurers-accuse-gilead-of-seeking-unreasonable-profits-from-remdesivir/ 2020-09-21T04:03:00+00:00 https://biolegacyresearch.com/russian-covid-19-therapeutic-coronavir-to-hit-pharmacy-shelves-in-coming-days/ 2020-09-21T04:03:00+00:00 https://biolegacyresearch.com/eu-signs-covid-19-vaccine-supply-deal-with-sanofi-gsk/ 2020-09-21T04:03:00+00:00 https://biolegacyresearch.com/ema-expert-group-recommends-dexamethasone-for-covid-19/ 2020-09-21T04:03:00+00:00 https://biolegacyresearch.com/roches-actemra-cuts-ventilator-need-in-covid-19-patients/ 2020-09-21T04:03:00+00:00 https://biolegacyresearch.com/lawmakers-lash-out-at-white-house-over-hahn-testimony-on-covid-19/ 2020-09-21T04:03:00+00:00 https://biolegacyresearch.com/fda-issues-temporary-guidance-on-resuming-normal-drug-manufacturing/ 2020-10-06T17:07:22+00:00 https://biolegacyresearch.com/fda-provides-clarifications-on-evaluations-for-intended-use/ 2020-10-06T17:11:09+00:00 https://biolegacyresearch.com/be-careful-with-fdas-new-compliant-manufacturing-resumption-guidance/ 2020-10-06T17:13:00+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-raps-five-firms-for-testing-other-violations/ 2020-10-06T17:26:40+00:00 https://biolegacyresearch.com/fda-outlines-prescription-drug-labeling-for-geriatric-patients/ 2020-10-06T17:29:15+00:00 https://biolegacyresearch.com/fda-offers-advice-on-control-of-nitrosamines-in-drugs/ 2020-10-06T17:31:46+00:00 https://biolegacyresearch.com/fda-details-asca-pilot-program-for-devices-in-new-guidance/ 2020-10-08T22:23:51+00:00 https://biolegacyresearch.com/fda-explains-whats-required-in-510ks-for-blood-glucose-monitoring-systems/ 2020-10-08T22:27:26+00:00 https://biolegacyresearch.com/devicemakers-urged-to-use-iso-10993-1-to-assess-biocompatibility/ 2020-10-08T22:43:35+00:00 https://biolegacyresearch.com/fda-harmonizes-emdr-system-with-international-codes/ 2020-10-08T22:46:07+00:00 https://biolegacyresearch.com/australia-invites-comment-on-its-planned-udi-system/ 2020-10-08T22:47:53+00:00 https://biolegacyresearch.com/fda-cites-nutravail-for-data-integrity-supplier-validation/ 2020-10-20T04:02:00+00:00 https://biolegacyresearch.com/uk-authorizes-covid-19-human-challenge-trial/ 2020-10-21T04:01:00+00:00 https://biolegacyresearch.com/sinopharm-to-supply-1-billion-covid-19-vaccine-doses-next-year/ 2020-10-21T04:01:00+00:00 https://biolegacyresearch.com/moderna-could-earn-eua-for-covid-19-vaccine-in-december-ceo-says/ 2020-10-21T04:01:00+00:00 https://biolegacyresearch.com/agios-withdraws-european-tibsovo-aml-submission/ 2020-10-21T04:02:00+00:00 https://biolegacyresearch.com/endo-gains-control-of-two-collagenase-therapies-in-biospecifics-purchase/ 2020-10-21T04:02:00+00:00 https://biolegacyresearch.com/covid-19-vaccine-developers-dont-need-pre-approval-inspections-for-emergency-use/ 2020-11-05T19:31:00+00:00 https://biolegacyresearch.com/gao-tells-fda-it-has-work-to-do-on-its-office-of-laboratory-safety/ 2020-11-05T19:34:38+00:00 https://biolegacyresearch.com/dr-reddys-temporarily-shutters-data-centers-following-cyber-attack/ 2020-11-05T19:35:00+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-raps-three-firms-for-gmp-other-lapses/ 2020-11-05T19:40:42+00:00 https://biolegacyresearch.com/new-postmarket-reporting-forms-detailed-in-draft-guidance/ 2020-11-05T19:42:01+00:00 https://biolegacyresearch.com/483-roundup-five-drugmakers-cited-for-quality-failures/ 2020-11-05T19:49:48+00:00 https://biolegacyresearch.com/former-fda-official-advises-on-best-gmp-practices-during-the-pandemic/ 2020-11-05T19:52:00+00:00 https://biolegacyresearch.com/fda-issues-first-warning-letter-for-product-with-a-covid-19-related-eua/ 2020-11-06T20:59:24+00:00 https://biolegacyresearch.com/tga-issues-guidance-on-device-conformity-assessments-during-covid-19/ 2020-11-06T21:00:59+00:00 https://biolegacyresearch.com/uk-establishes-new-medical-device-information-system/ 2020-11-06T21:02:56+00:00 https://biolegacyresearch.com/health-canada-updates-guidelines-on-covid-19-testing/ 2020-11-06T21:04:33+00:00 https://biolegacyresearch.com/fda-warns-of-infection-risk-from-heater-coolers/ 2020-11-06T21:06:36+00:00 https://biolegacyresearch.com/imdrf-advances-device-conformity-assessment-documents/ 2020-11-06T21:11:26+00:00 https://biolegacyresearch.com/meet-sooner-with-us-biosimilars-industry-asks-fda/ 2020-11-20T05:01:00+00:00 https://biolegacyresearch.com/how-moderna-is-taking-on-the-pharma-giants-with-its-covid-19-vaccine/ 2020-11-20T05:01:00+00:00 https://biolegacyresearch.com/fda-issues-advice-on-cross-labeling-for-oncology-drugs/ 2020-11-20T05:01:00+00:00 https://biolegacyresearch.com/roches-actemra-improves-covid-19-survival-study-claims/ 2020-11-20T05:01:00+00:00 https://biolegacyresearch.com/russia-denies-pause-in-covid-19-vaccine-trial/ 2020-11-20T05:01:00+00:00 https://biolegacyresearch.com/astrazeneca-vaccine-results-likely-by-christmas-with-early-efficacy-findings-in-weeks/ 2020-11-20T05:01:00+00:00 https://biolegacyresearch.com/sanofi-gets-priority-review-for-investigational-enzyme-therapy/ 2020-11-20T05:01:00+00:00 https://biolegacyresearch.com/fda-official-gives-update-on-inspections-during-covid-19-pandemic/ 2020-12-11T17:04:00+00:00 https://biolegacyresearch.com/fda-offers-sanitation-advice-to-drug-compounders/ 2020-12-11T17:05:00+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-targets-sham-covid-19-treatments/ 2020-12-11T17:09:00+00:00 https://biolegacyresearch.com/fda-cites-ucsf-radiopharmaceutical-facility-for-quality-failures/ 2020-12-11T17:15:42+00:00 https://biolegacyresearch.com/fda-finds-microbial-contamination-at-puerto-rico-plant/ 2020-12-11T17:21:48+00:00 https://biolegacyresearch.com/fda-raps-otc-drugmaker-in-louisiana-for-range-of-issues/ 2020-12-11T17:23:13+00:00 https://biolegacyresearch.com/microsoft-warns-of-cyberattacks-against-covid-19-vaccine-drug-developers/ 2020-12-11T17:24:34+00:00 https://biolegacyresearch.com/sanofi-draws-complete-response-letter-over-third-party-manufacturer/ 2020-12-11T17:25:50+00:00 https://biolegacyresearch.com/mdsap-audits-go-remote-during-the-pandemic/ 2020-12-11T17:31:51+00:00 https://biolegacyresearch.com/canada-issues-guidance-on-using-uv-radiation-for-decontaminating-devices/ 2020-12-11T17:33:02+00:00